Skip to main content
×
×
Home
  • Print publication year: 2010
  • Online publication date: November 2010

Section 3 - Understanding the causes of anxiety

Summary
Social phobia turned out to be a severe clinical problem for patients whose fear of evaluation and scrutiny by others interfered with social functioning as well as performance. The study comparing phenelzine, atenolol, and placebo in social anxiety disorder became a model to be followed by subsequent trials. Social anxiety disorder appears to be a highly prevalent condition. While the most recent epidemiologic survey, the NESARC, has found a lifetime prevalence of 5% as opposed to the 13% found in the original National Comorbidity Survey (NCS) study, it would still appear that social anxiety disorder is one of the more common psychiatric conditions. Future studies should go a long way toward clarifying the pathophysiology of social anxiety disorder, which in turn should facilitate diagnosis as well as treatment. Positron emission tomography (PET) scans of patients giving speeches are beginning to delineate the brain circuits relevant to social phobic symptomatology.
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Anxiety Disorders
  • Online ISBN: 9780511777578
  • Book DOI: https://doi.org/10.1017/CBO9780511777578
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×

References

Alsobrook, J. P., Zohar, A. H., Leboyer, M., et al. (2001). Association between the COMT locus and obsessive–compulsive disorder in females but not in males. American Journal of Medical Genetics, 114, 116–120.
Arbelle, S., Benjamin, J., Golin, M., et al. (2003). Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. American Journal of Psychiatry, 160, 671–676.
Arnold, P., Sicard, T., Burroughs, E., Richter, M., & Kennedy, J. (2006). Glutamate transporter gene SLC1A1 associated with obsessive–compulsive disorder. Archives of General Psychiatry, 63, 769–776.
Azzam, A., & Mathews, C. (2003). Meta-analysis of the association between the catecholamine-O-methyl-transferase gene and obsessive–compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 123B, 64–69.
Baca-Garcia, E., Vaquero-Lorenzo, C., Diaz-Hernandez, M., et al. (2007). Association between obsessive–compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 416–420.
Battaglia, M., Bajo, S, Strambi, LF, et al. (1997). Physiological and behavioral responses to minor stressors in offspring of patients with panic disorder. Journal of Psychiatric Research, 31, 365–376.
Bellodi, L., Scuito, G., Guiseppina, D., & Ronchi, P. (1992). Psychiatric disroders in the families of patients with obsessive–compulsive disorder. Psychiatry Research, 42, 111–120.
Bellodi, L., Perna, G., Caldirola, D., et al. (1998). CO2- induced panic attacks: a twin study. American Journal of Psychiatry, 155, 1184–1188.
Bengel, D., Greenberg, B. D., Cora-Locatelli, G., et al. (1999). Association of the serotonin transporter promoter regulatory region polymorphism and obsessive–compulsive disorder. Molecular Psychiatry, 4, 463–466.
Biederman, J., Hirshfeld-Becker, D. R., Rosenbaum, J. F., et al. (2001). Further evidence of association between behavioral inhibition and social anxiety in children. American Journal of Psychiatry, 158, 1673–1679.
Billett, E. A., Richter, M. A., King, N., et al. (1997). Obsessive compulsive disorder, response to serotonin reuptake inhibiters and the serotonin transporter gene. Molecular Psychiatry, 2, 403–406.
Billett, E. A., Richter, M., Sam, F., et al. (1998). Investigation of dopamine system genes in obsessive–compulsive disorder. Psychiatric Genetics, 8, 163–169.
Bolton, D., Eley, T. C., O’Connor, T. G., et al. (2006). Prevalence and genetic and environmental influences on anxiety disorders in 6-year-old twins. Psychological Medicine, 36, 335–344.
Camarena, B., Rinetti, G., Cruz, C., et al. (2001a). Association study of the serotonin transporter gene polymorphism in obsessive–compulsive disorder. International Journal of Neuropsychopharmacology, 4, 269–272.
Camarena, B., Rinetti, G., Cruz, C., et al. (2001b). Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive–compulsive disorder. American Journal of Medical Genetics, 105, 279–282.
Camarena, B., Loyzaga, C., Aguilar, A., Weissbecker, K. & Nicolini, H. (2007). Association study between the dopamine D4 gene and obsessive–compulsive disorder. European Neuropsychopharmacology, 17, 406–409.
Cavallini, M., Di Bella, D., Siliprandi, F., Malchiodi, F., & Bellodi, L. (2002). Exploratory factor analysis of obsessive–compulsive patients and association with 5-HTTLPR polymorphism. American Journal of Medical Genetics, 114, 347–353.
Chabane, N., Millet, B., Delorme, R., et al. (2004). Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive–compulsive disorder by case control and family association study in humans. Neuroscience Letters, 363, 154–156.
Chacon, P., Rosario-Campos, M. C., Pauls, D. L., et al. (2007). Obsessive–compulsive symptoms in sibling pairs concordant for obsessive–compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B, 551–555.
Chantarujikapong, S. I., Scherrer, J. F., Xian, H., et al. (2001). A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men. Psychiatry Research, 103, 133–145.
Comings, D. E., Comings, B. G., Muhleman, D., et al. (1991). The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA, 266, 1793–1800.
Comings, D. E., Muhleman, D., & Gysin, R. (1996). Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: A study and replication. Biological Psychiatry, 40, 368–372.
Craddock, N., O’Donovan, M. C., & Owen, M. J. (2008). Genome-wide association studies in psychiatry: lessons from early studies of non-psychiatric and psychiatric phenotypes. Molecular Psychiatry, 13, 649–653.
Crowe, R. R., Goedken, R., Samuelson, S., et al. (2001). Genomewide survey of panic disorder. American Journal of Medical Genetics, 105, 105–109.
Deckert, J., Catalano, M., & Heils, A. (1997). Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatric Genetics, 7, 45–47.
Deckert, J., Catalano, M., Syagailo, Y., et al. (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Human Molecular Genetics, 8, 621–624.
Denys, D., Van Nieuwerburgh, F., Deforce, D., & Westenberg, H. (2006). Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive–compulsive disorder in males. European Neuropsychopharmacology, 16, 446–450.
Di Bella, D., Cavallini, M. C., & Bellodi, L. (2002). No association between obsessive–compulsive disorder and the 5-HT1Dβ receptor gene. American Journal of Psychiatry, 159, 1783–1785.
Dickel, D. E., Veenstra-VanderWeele, J., Cox, N. J., et al. (2006). Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive–compulsive disorder. Archives of General Psychiatry, 63, 778–785.
DiLalla, L., Kagan, J., & Reznick, J. (1994). Genetic etiology of behavioral inhibition among 2-year-old children. Infant Behavior Development, 17, 405–412.
Distel, M. A., Vink, J. M., & Willemsen, G. (2008). Heritability of self-reported phobic fear. Behavior Genetics, 38, 24–33.
do Rosario-Campos, M., Leckman, J., Curi, M., et al. (2005). A family study of early onset obsessive–compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 136B, 92–97.
Domschke, K., Deckert, J., O’Donovan, M. C., & Glatt, S. J. (2007). Meta-analysis of COMT val158met in panic disorder: Ethnic heterogeneity and gender specificity. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B, 667–673.
Eley, T. C., Bolton, D., O’Connor, T. G., et al. (2003). A twin study of anxiey-related behaviors in pre-school children. Journal of Child Psychology and Psychiatry, 44, 945–960.
Enoch, M. A., Xu, K., Ferro, E., Harris, C. R., & Goldman, D. (2003). Genetic origins of anxiety in women: a role for a functional COMT polymorphism. Psychiatric Genetics, 13, 33–41.
Erdal, M., Tot, S., Yazici, K., et al. (2003). Lack of association of catechol-o-methyltransferase gene polymorphism in obsessive–compulsive disorder. Depression and Anxiety, 18, 41–45.
Fehr, C., Schleicher, A., Szegedi, A., et al. (2001). Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders, and narcolepsy. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 965–982.
Freitag, C. M., Domschke, K., Rothe, C., et al. (2006). Interaction of serotonergic and noradrenergic gene variants in panic disorder. Psychiatric Genetics, 16, 59–65.
Frisch, A., Michaelovsky, E., Rockah, R., et al. (2000). Association between obsessive–compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. European Neuropsychopharmacology, 10, 205–209.
Furmark, T., Tillfors, M., Garpenstrand, H., et al. (2004). Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neuroscience Letters, 362, 189–192.
Fyer, A., Mannuzza, S., Gallops, M., et al. (1990). Familial transmission of simple phobias and fears. A preliminary report. Archives of General Psychiatry, 47, 252–256.
Fyer, A., Mannuzza, S., Chapman, T., Liebowitz, M., & Klein, D. (1993). A direct interview family study of social phobia. Archives of General Psychiatry, 50, 286–293.
Fyer, A., Mannuzza, S., Chapman, T., et al. (1996). Panic disorder and social phobia: effects of comorbidity on familial transmission. Anxiety, 2, 173–178.
Fyer, A., Lipsitz, J., Mannuzza, S., Aronowitz, B., & Chapman, T. (2005). A direct interview family study of obsessive–compulsive disorder. I. Psychological Medicine, 35, 1611–1621.
Fyer, A., Hamilton, S., Durner, M., et al. (2006). A third-pass genome scan in panic disorder: evidence for multiple susceptability loci. Biological Psychiatry, 60, 388–401.
Gelernter, J., Southwick, S., Goodson, S., et al. (1999). No association between D2 dopamine receptor (DRD2) ‘A’ system alleles, or DRD2 haplotypes, and posttraumatic stress disorder. Biological Psychiatry, 45, 620–625.
Gelernter, J., Bonvicini, K., Page, G., et al. (2001). Linkage genome scan for loci predisposing to panic disorder or agoraphobia. American Journal of Medical Genetics, 105, 548–557.
Gelernter, J., Page, G. P., Bonvicini, K., et al. (2003). A chromosome 14 risk locus for simple phobia: Results from a genomewide linkage scan. Molecular Psychiatry, 8, 71–82.
Gelernter, J., Page, G., Stein, M., & Woods, S. (2004). Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus. American Journal of Psychiatry, 161, 59–66.
Gerstein, M., Bruce, C., Rozowsky, J., et al. (2007) What is a gene, post-ENCODE? History and updated definition. Genome Research, 17, 669–681.
Goldsmith, H., & Lemery, K. (2000). Linking temperamental anxiety symptoms: a behavior-genetic perspective. Biological Psychiatry, 48, 1199–1209.
Goldstein, R., Wickramante, P., Horwath, E., & Weissman, M. (1997). Familial aggregation and pheonmenology of “early”-onset (at or before age 20 years) panic disorder. Archives of General Psychiatry, 54, 271–278.
Gordon, J. A., & Hen, R. (2004). The serotonergic system and anxiety. NeuroMolecular Medicine, 5, 27–40.
Gregory, A., Lau, J. Y. F., & Eley, T. C. (2008). Finding gene–environment interactions for generalised anxiety disorder. European Archives of Psychiatry and Clinical Neuroscience, 258, 69–75.
Hamilton, S., Haghighi, F., Heiman, G., et al. (2000). Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder. American Journal of Medical Genetics, 96, 324–330.
Hamilton, S., Fyer, A., Durner, M., et al. (2003). Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proceedings from the National Academy of Sciences of the USA, 100, 2550–2555.
Hamilton, S., Slager, S. L., Mayo, D., et al. (2004a). Investigation of polymorphisms in the CREM gene in panic disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 126B, 111–115.
Hamilton, S. P., Slager, S. L., de Leon, A. B., et al. (2004b). Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology, 29, 558–565.
Hanna, G. L., Veenstra-VanderWeele, J., Cox, N. J., et al. (2002). Genome-wide linkage analysis of families with obsessive–compulsive disorder ascertained through pediatric probands. American Journal of Medical Genetics, 114, 541–552.
Hemmings, S., & Stein, D. (2006). The current status of association studies in obsessive–compulsive disorder. Psychiatric Clinics of North America, 29, 411–444.
Hemmings, S., Kinnear, C., Niehaus, D., et al. (2003). Investigating the role of dopaminergic and serotonergic candidate genes in obsessive–compulsive disorder. European Neuropsychopharmacology, 13, 93–98.
Hemmings, S., Kinnear, C., Lochner, C., et al. (2004). Early- versus late-onset obsessive–compulsive disorder: investigating genetic and clinical correlates. Psychiatric Annals, 128, 175–182.
Hetherington, E., Reiss, D., & Plomin, R. (1993) Separate Social Worlds of Siblings: the Impact of Nonshared Envionment on Development. Hillsdale, NJ: Lawrence Erlbaum Associates.
Hettema, J. M., Neale, M. C., & Kendler, K. S. (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. American Journal of Psychiatry, 158, 1568–1578.
Hettema, J. M., Prescott, C. A., & Kendler, K. S. (2004). Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. American Journal of Psychiatry, 161, 1581–1587.
Hettema, J. M., Prescott, C. A., Myers, J. M., Neale, M. C., & Kendler, K. S. (2005). The structure of genetic and environmental risk ractors for anxiety disorders in men and women. Archives of General Psychiatry, 62, 182–189.
Hettema, J. M., Neale, M. C., Myers, J. M., Prescott, C. A., & Kendler, K. S. (2006a). A population-based twin study of the relationship between neuroticism and internalizing disorders. American Journal of Psychiatry, 163, 857–864.
Hettema, J. M., An, S. S., Neale, M. C., et al. (2006b). Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Molecular Psychiatry, 11, 794.
Hodges, L., Weissman, M., Haghighi, F., et al. (2009). Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 150B, 65–73.
Horwath, E., Wolk, S., Goldstein, R., et al. (1995). Is the comorbidity between social phobia and panic disorder due to familial cotransmission or other factors. Archives of General Psychiatry, 52, 574–582.
Hu, X. Z., Lipsky, R., Zhu, G., et al. (2006). Serotonin transporter promoter gain-of-function genotypes are linked to obsessive–compulsive disorder. American Journal of Human Genetics, 78, 815–826.
Hunnerkopf, R., Strobel, A., Gutknecht, L., Brocke, B., & Lesch, K. P. (2007). Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology, 32, 2552–2560.
Inada, Y., Yoneda, H., Koh, J., et al. (2003). Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Research, 118, 25–31.
Ishiguro, H., Arinami, T., Yamada, K., et al. (1997). An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population. Psychiatry and Clinical Neurosciences, 51, 333–335.
Jang, K. L., Stein, M. B., Taylor, S., & Livesley, W. J. (1999). Gender differences in the etiology of anxiety sensitivity: a twin study. Journal of Gender Specific Medicine, 2, 39–44.
Jardine, R., Martin, N., & Henderson, A. (1984). Genetic covariation between neuroticism and the symptoms of anxiety and depression. Genetic Epidemiology, 1, 89–107.
Johnson, J., Cohen, P., Kasen, S., & Brook, J. (2008). Parental concordance and offspring risk for anxiety, conduct, depressive, and substance use disorders. Psychopathology, 41, 124–128.
Jorm, A., Prior, M., Sanson, A., et al. (2000). Association of a functional polymorphism of the serotonin transporter gene with anxiety-related temperament and behavior problems in children: A longitudinal study from infancy to the mid-teens. Molecular Psychiatry, 5, 542–547.
Kagan, J., Reznick, J., & Gibbons, J. (1989). Inhibited and uninhibited types of children. Child Development, 60, 838–845.
Karayiorgou, M., Alternus, M., Galke, B., et al. (1997). Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive–compulsive disorder. Proceedings of the National Academy of Sciences of the USA, 94, 4572–4575.
Karayiorgou, M., Sobin, C., Blundell, M., et al. (1999). Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive–compulsive disorder. Biological Psychiatry, 45, 1178–1189.
Kendler, K., Neale, M., Kessler, R., Heath, A., & Eaves, L. (1993). Panic disorder in women: A population-based twin study. Psychological Medicine, 23, 397–406.
Kendler, K., Walters, E., Truett, K. R., et al. (1995). A twin family study of self-report symptoms of panic, phobia, and somatization. Behavior Genetics, 25, 499–515.
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999). Fears and phobias: reliability and heritability. Psychological Medicine, 29, 539–553.
Kendler, K. S., Gardner, C. O., & Prescott, C. A. (2001a). Panic syndromes in a population-based sample of male and female twins. Psychological Medicine, 31, 989–1000.
Kendler, K. S., Myers, J., Prescott, C. A., & Neale, M. C. (2001b). The genetic epidemiology of irrational fears and phobias in men. Archives of General Psychiatry, 58, 257–265.
Kendler, K., Gardner, C. O., Annas, P., et al. (2008). A longitudinal twin study of fears from middle childhood to early adulthood: evidence for a developmentally dynamic genome. Archives of General Psychiatry, 65, 421–429.
Kennedy, J. L., Neves-Pereira, M., King, N., et al. (2001). Dopamine system genes not linked to social phobia. Psychiatric Genetics, 11, 213–217.
Kessler, R., Chiu, W., Demler, O., Merikangas, K., & Walters, E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 25, 617–627.
Kilpatrick, D. G., Koenen, K. C., Ruggiero, K. J., et al. (2007). The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. American Journal of Psychiatry, 164, 1693–1699.
Kim, S., Lee, H., & Kim, C. (2005). Obsessive–compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology, 52, 176–182.
Kinnear, C., Niehaus, D., Moolman-Smook, J., et al. (2000). Obsessive–compulsive disorder and the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene (SLC6A4): a negative association study in the Afrikaner population. International Journal of Neuropsychopharmacology, 3, 327–331.
Kirk, K., Birley, A., Statham, D., Haddon, B., et al. (2000). Anxiety and depression in twin and sib pairs extremely discordant and concordant for neuroticism: prodromus to a linkage study. Twin Research and Human Genetics, 3, 299–309.
Knowles, J., Fyer, A., Vieland, V., et al. (1998). Results of a genome-wide genetic screen for panic disorder. American Journal of Medical Genetics, 81, 139–147.
Koenen, K. C. (2007). Genetics of posttraumatic stress disorder: review and recommendations for future studies. Journal of Traumatic Stress Studies, 20, 737–750.
Koenen, K. C., Nugent, N. R., & Amstadter, A. B. (2008). Gene–environment interaction in posttraumatic stress disorder: review, strategy and new directions for future research. European Archives of Psychiatry and Clinical Neuroscience, 258, 82–96.
Koenen, K. C., Amstadter, A. B., Ruggiero, K. J., et al. (2009). RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depression and Anxiety, 26, 309–315.
Lee, H. J., Lee, M. S., Kang, R. H., et al. (2005). Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depression and Anxiety, 21, 135–139.
Lenane, M. C., Swedo, S. E., Leonard, H., et al. (1990). Psychiatric disorders in first degree relatives of children and adolescents with obsessive compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 407–412.
Leygraf, A., Hohoff, C., Freitag, C., et al. (2006). Rgs 2 gene polymorphisms as modulators of anxiety in humans?Journal of Neural Transmission, 113, 1921–1925.
Lichtenstein, P., & Annas, P. (2000). Heritability and prevalence of specific fears and phobias in childhood. Journal of Child Psychology and Psychiatry and Allied Disciplines, 41, 927–937.
Lochner, C., Hemmings, S., Seedat, S., et al. (2007). Genetics and personality traits in patients with social anxiety disorder: a case–control study in South Africa. European Neuropsychopharmacology, 17, 321–327.
Logue, M., Vieland, V., Goedken, R., & Crowe, R. R. (2003). Bayesian analysis of a previously published genome screen for panic disorder reveals new and compelling evidence for linkage to chromosome 7. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 121B, 95–99.
Low, N. C. P., Cui, L., & Merikangas, K. R. (2008). Community versus clinic sampling: Effect on the familial aggregation of anxiety disorders. Biological Psychiatry, 63, 884–890.
Maier, W., Lichtermann, D., Minges, J., Oehrlein, A., & Franke, P. (1993). A controlled family study in panic disorder. Journal of Psychiatric Research, 27, 79–87.
Mannasis, K., Bradley, S, Goldberg, S, Hood, J, Swinson, R. (1995). Behavioural inhibition, attachment and anxiety in children of mothers with anxiety disorders. Canadian Journal of Psychiatry, 40, 87–92.
Maron, E., Nikopensius, T., Koks, S., et al. (2005). Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatric Genetics, 15, 17–24.
Matheny, A. (1989). Children’s behavioral inhibition over age and across situations: genetic similarity for a trait during change. Journal of Personality, 57, 215–235.
Matsushita, S., Muramatsu, T., Kimura, M., et al. (1997). Serotonin transporter gene regulatory region polymorphism and panic disorder. Molecular Psychiatry, 2, 390–392.
McDougle, C. J., Epperson, C. N., Price, L. H., & Gelernter, J. (1998). Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Molecular Psychiatry, 3, 270–273.
McGrath, M., Kawachi, I., Ascherio, A., et al. (2004). Association between catechol-O-methyltransferase and phobic anxiety. American Journal of Psychiatry, 161, 1703–1705.
Meira-Lima, I., Shavitt, R., Miguita, K., et al. (2004). Association analysis of the catechol-omethyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive–compulsive disorder. Genes, Brain, and Behavior, 3, 75–79.
Mendlewicz, J., Papadimitriou, G., & Wilmotte, J. (1993). Family study of panic disorder: comparison with generalized anxiety disorder, major depression and normal subjects. Psychiatric Genetics, 3, 73–78.
Middledorp, C., Birley, A., Cath, D. G., et al. (2005). Familial clustering of major depression and anxiety disorders in Australian and Dutch twins and siblings. Twin Research and Human Genetics, 8, 609–615.
Millet, B., Chabane, N., Delorme, R., et al. (2003). Association between the dopamine receptor D4 (DRD4) gene and obsessive–compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 116B, 55–59.
Munafo, M., Clark, T., & Flint, J. (2005). Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis. Molecular Psychiatry, 10, 415–419.
Nestadt, G., Samuels, J., Riddle, M., et al. (2000). A family study of obsessive–compulsive disorder. Archives of General Psychiatry, 57, 358–363.
Newman, S., & Bland, R. (2006). A population-based family study of DSM-III generalized anxiety disorder. Psychological Medicine, 36, 1275–1281.
Nicolini, H., Cruz, C., Camarena, B., et al. (1996). DRD2, DRD3, and 5HT2A receptor genes polymorphisms in obsessive–compulsive disorder. Molecular Psychiatry, 1, 461–465.
Niehaus, D., Kinnear, C., Corfield, V., et al. (2001). Association between a catechol-o-methyltransferase polymorphism and obsessive–compulsive disorder in the Afrikaner population. Journal of Affect Disorders, 65, 61–65.
Noyes, R., Crowe, R. R., Harris, E., et al. (1986). Relationship between panic disorder and agoraphobia: a family study. Archives of General Psychiatry, 43, 227–232.
Noyes, R., Clarkson, C., Crowe, R., Yates, W., & McChesney, C. (1987). A family study of generalized anxiety disorder. American Journal of Psychiatry, 144, 1019–1024.
Nugent, N. R., Amstadter, A. B., & Koenen, K. C. (2008). Genetics of post-traumatic stress disorder: informing clinical conceptualizations and promoting future research. American Journal of Medical Genetics C: Seminars in Medical Genetics, 148C, 127–132.
Ohara, K., Nagai, M., Suzuki, Y., Ochiai, M., & Ohara, K. (1998). No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Research, 80, 145–148.
Ohara, K., Suzuki, Y., Ochiai, M., et al. (1999). A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 23, 55–65.
Pauls, D. (2008). The genetics of obsessive–compulsive disorder: a review of the evidence. American Journal of Medical Genetics C: Seminars in Medical Genetics, 148C, 133–139.
Pauls, D., Alsobrook, J. P., Goodman, W., Rasmussen, S., & Leckman, J. F. (1995). A family study of obsessive–compulsive disorder. American Journal of Psychiatry, 152, 76–84.
Perna, G., Caldirola, D., Arancio, C., & Bellodi, L. (1997). Panic attacks: a twin study. Psychiatry Research, 66, 69–71.
Plomin, R., Emde, R., Bruaungart, J., et al. (1993). Genetic change and continuity from fourteen to twenty months: the MacArthur Longitudinal Twin Study. Child Development, 64, 1354–1376.
Plomin, R., DeFries, J. C., McClearn, G. E., & McGuffin, P. (2001). Behavioral Genetics. New York, NY: Worth.
Poulton, R., Andrews, G., & Millichamp, J. (2008). Gene–environment interaction and the anxiety disorders. European Archives of Psychiatry and Clinical Neuroscience, 258, 65–68.
Risch, N. J., & Merikangas, K. (1996). The future of genetic studies of complex human diseases. Science, 273, 1516–1517.
Robinson, J., Kagan, J., Reznick, J., & Corley, P. A. (1992). The heritability of inhibited and uninhibited behavior: a twin study. Development and Psychopathology, 28, 1030–1037.
Rosenbaum, J., Biederman, J., Hirshfeld-Becker, D. R., et al. (2000). A controlled study of behavioral inhibition in children of parents with panic disorder and depression. American Journal of Psychiatry, 157, 2002–2010.
Rowe, D., Stever, C., Gard, J., et al. (1998). The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behavior Genetics, 28, 215–225.
Sack, W. H., Clarke, G. N., & Seeley, J. (1995). Posttraumatic stress disorder across two generations of Cambodian refugees. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1160–1166.
Saiz, P. A., Garcia-Portilla, M. P., Arango, C., et al. (2008). Association study between obsessive–compulsive disorder and serotonergic candidate genes. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32, 765–770.
Samochowiec, J., Hajduk, A., Samochowiec, A., et al. (2004). Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Research, 128, 21–26.
Schindler, K., Richter, M. A., Kennedy, J. L., Pato, M., & Pato, C. (2000). Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. American Journal of Medical Genetics, 96, 721–724.
Schinka, J. A. (2005). Measurement scale does moderate the association between the serotonin transporter gene and trait anxiety: comments on Munafo et al. Molecular Psychiatry, 10, 892–893.
Schwartz, C., Snidman, N., & Kagan, J. (1999). Adolescent social anxiety as an outcome of inhibited temperament in childhood. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1008–1015.
Seckl, J., & Meaney, M. (2006). Glucocorticoid “programming” and PTSD risk. Annals of the New York Academy of Sciences, 1071, 351–378.
Segman, R. H., Cooper-Kazaz, R., Macciardi, F., et al. (2002). Association between the dopamine transporter gene and posttraumatic stress disorder. Molecular Psychiatry, 7, 903–907.
Shifman, S., Bhomra, A., & Smiley, S. (2008). A whole genome association study of neuroticism using DNA pooling. Molecular Psychiatry, 13, 302–312.
Shugart, Y., Samuels, J., Willour, V., et al. (2006). Genomewide linkage scan for obsessive–compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Molecular Psychiatry, 11, 763–770.
Skinner, M., Anway, M. D., Savenkova, M. I., Gore, A. C., & Crews, D. (2008). Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PloS ONE, 3 (11), e3745.
Skre, I., Onstad, S., Torgesen, S., Lygren, S., & Kringlen, E. (1993). A twin study of DSM-III-R anxiety disorders. Acta Psychiatrica Scandinavica, 88, 85–92.
Smoller, J. W. (2008). Genetics of mood and anxiety disorders. In J. W. Smoller, B. R. Sheidley, & M. T. Tsuang, eds., Psychiatric Genetics: Applications in Clinical Practice. Washington, DC: American Psychiatric Publishing, pp. 131–176.
Smoller, J., Acerno, J., Rosenbaum, J., et al. (2001a). Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. American Journal of Medical Genetics, 105, 195–206.
Smoller, J., Rosenbaum, J. F., Biederman, J., et al. (2001b). Genetic association analysis of behavioral inhibition using candidate loci from mouse models. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 105B, 226–235.
Smoller, J., Rosenbaum, J. F., Biederman, J., et al. (2003). Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biological Psychiatry, 54, 1376–1381.
Smoller, J., Yamaki, L. H., Fagerness, J. A., et al. (2005). The corticotropin releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biological Psychiatry, 57, 1485–1492.
Smoller, J., Paulus, M. P., Fagerness, J. A., et al. (2008a). Influence of RGS2 on anxiety-related temperament, personality, and brain function. Archives of General Psychiatry, 65, 298–308.
Smoller, J., Gardner-Schuster, E., & Covino, J. (2008b). The genetic basis of panic and phobic anxiety disorders. American Journal of Medical Genetics C: Seminars in Medical Genetics, 148C, 118–126.
Stein, M., Chartier, M., Hazen, A., et al. (1998a). A direct-interview family study of generalized social phobia. American Journal of Psychiatry, 155, 90–97.
Stein, M. B., Chartier, M. J., Kozak, M. V., King, N., & Kennedy, J. L. (1998b). Genetic linkage to the serotonin transporter protein and 5HT2A receptor genes excluded in generalized social phobia. Psychiatry Research, 81, 283–291.
Stein, M. B., Jang, K. J., & Livesley, J. (1999). Heritability of anxiety sensitivity: a twin study. American Journal of Psychiatry, 156, 246–251.
Stein, M. B., Jang, K. J., Taylor, S., Vernon, P. A., & Livesley, W. J. (2002). Genetic and environmental influences on trauma exposure and posttraumatic stress disorder: a twin study. American Journal of Psychiatry, 159, 1675–1681.
Stein, M., Fallin, M., Schork, N., J, & Gelernter, J. (2005). COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology, 30, 2092–2102.
Stein, M. B., Seedat, S., & Gelernter, J. (2006). Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology, 187, 68–72.
Stein, M. B., Schork, N., J, & Gelernter, J. (2008). Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology, 33, 312–319.
Stewart, S., Fagerness, J. A., Platko, J., et al. (2007). Association of the SLCA1 glutamate transporter gene and obsessive–compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B, 1027–1033.
Strug, L., Suresh, R., Fyer, A., et al. (2010). Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Molecular Psychiatry, 15, 166–176.
Tadic, A., Rujescu, D., Szegedi, A., et al. (2003). Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 117, 1–6.
Talati, A., Ponniah, K., Strug, L., et al. (2008). Panic disorder, social anxiety disorder, and a possible medical syndrome previously linked to chromosome 13. Biological Psychiatry, 63, 594–601.
Taylor, S., Jang, K. L., Stewart, S. H., & Stein, M. B. (2008). Etiology of the dimensions of anxiety sensitivity: a behavioral-genetic analysis. Journal of Anxiety Disorders, 22, 899–914.
Thorgeirsson, T. E., Oskarsson, H., Desnica, N., et al. (2003). Anxiety with panic disorder linked to chromosome 9q in Iceland. American Journal of Human Genetics, 72, 1221–1230.
Tochigi, M., Hibino, H., Otowa, T., et al. (2006). Association between dopamine D4 receptor (DRD4) exon III polymorphism and neuroticism in the Japanese population. Neuroscience Letters, 398, 333–336.
Torgersen, S. (1983). Genetic factors in anxiety disorders. Archives of General Psychiatry, 40, 1085–1089.
Tot, S., Erdal, M., Yazici, K., Yazici, A., & Metin, O. (2003). T102C and -1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive–compulsive disorder. European Psychiatry, 18, 249–254.
True, W. J., Rice, J., Eisen, S. A., et al. (1993). A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Archives of General Psychiatry, 50, 257–264.
Turner, S., Bieidel, D., & Wolff, P. (1996). Is behavioral inhibition related to the anxiety disorders?Clinical Psychology Review, 16, 157–172.
van Beek, N., & Griez, E. (2003). Anxiety sensitivity in first-degree relatives of patients with panic disorder. Behavior Research and Therapy, 41, 949–957.
van Grootheest, D., Bartels, M., Cath, D., et al. (2007). Genetic and environmental contributions underlying stability in childhood obsessive–compulsive behavior. Biological Psychiatry, 61, 308–315.
van Grootheest, D., Cath, D., Beekman, A., & Boomsma, D. (2005). Twin studies on obsessive–compulsive disorder: A review. Twin Research Human Genetics, 8, 450–458.
Wacker, J., Reuter, M., Hennig, J., & Stemmler, G. (2006). Sexually dimorphic link between dopamine D2 receptor gene and neuroticism–anxiety. Neuroreport, 16, 611–614.
Walitza, S., Wewetzer, C., Warnke, A., et al. (2002). 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive–compulsive disorders. Molecular Psychiatry, 7, 1054–1057.
Walitza, S., Wewetzer, C., Gerlach, M., et al. (2004). Transmission disequilibrium studies in children and adolescents with obsessive–compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. Journal of Neural Transmission, 111, 817–825.
Weissman, M., Fyer, A., Haghighi, F., et al. (2000). Potential panic disorder syndrome: Clinical and genetic linkage evidence. American Journal of Medical Genetics, 96, 24–35.
Weissman, M., Gross, R., Fyer, A., et al. (2004). Interstitial cystitis and panic disorder: a potential genetic syndrome. Archives of General Psychiatry, 61, 273–279.
Willis-Owen, S. A. G., Fullerton, J., Surtees, P. G., et al. (2005). The Val66Met coding variant of the brain-derived neurotrophic factor (BDNF) gene does not contribute toward variation in the personality trait neuroticism. Biological Psychiatry, 58, 738–742.
Willour, V., Yao Shugart, Y., Samuels, J., et al. (2004). Replication study supports evidence for linkage to 9p24 in obsessive–compulsive disorder. American Journal of Human Genetics, 75, 508–513.
Yehuda, R., Halligan, S. L., & Bierer, L. M. (2001). Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring. Journal of Psychiatric Research, 35, 261–270.
Yehuda, R., Bell, A., Bierer, L., & Schmeidler, J. (2008). Maternal, not paternal, PTSD is related to increased risk for PTSD in offspring of Holocaust survivors. Journal of Psychiatric Research, 42, 1104–1111.
You, J.-S., Hu, S.-Y., Chen, B., & Zhang, H. G. (2005). Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder. Psychiatric Genetics, 15, 7–11.
Young, B. R., Lawford, B. R., Noble, E. P., et al. (2002). Harmful drinking in military veterans with posttraumatic stress disorder: association with the D2 dopamine receptor A1 allele. Alcohol & Alcoholism, 37, 451–456.

References

American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
Andreatini, R., Blanchard, C., Blanchard, R., et al. (2001). The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis. Brazilian Journal of Medical and Biological Research, 34, 145–154.
Arguello, P. A., & Gogos, J. A. (2006). Modeling madness in mice: one piece at a time. Neuron, 52, 179–196.
Belin, D., Mar, A. C., Dalley, J. W., Robbins, T. W., & Everitt, B. J. (2008). High impulsivity predicts the switch to compulsive cocaine-taking. Science, 320, 1352–1355.
Belzung, C., Misslin, R., Vogel, E., Dodd, R. H., & Chapouthier, G. (1987). Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/dark choice situation. Pharmacology, Biochemistry, and Behavior, 28, 29–33.
Blanchard, D. C., Hynd, A. L., Minke, K. A., Minemoto, T., & Blanchard, R. J. (2001a). Human defensive behaviors to threat scenarios show parallels to fear- and anxiety-related defense patterns of non-human mammals. Neuroscience and Biobehavioral Reviews, 25, 761–770.
Blanchard, D. C., Griebel, G., & Blanchard, R. J. (2001b). Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neuroscience and Biobehavioral Reviews, 25, 205–218.
Blier, P., Pineyro, G., el Mansari, M., Bergeron, R., & de Montigny, C. (1998). Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Annals of the New York Academy of Sciences, 861, 204–216.
Bloom, F. E. & Kupfer, D. J., eds. (1995). Psychopharmacology: the Fourth Generation of Progress. New York, NY: Raven Press.
Bodnoff, S. R., Suranyi-Cadotte, B., Quirion, R., & Meaney, M. J. (1989). A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berlin), 97, 277–279.
Borsini, F., Podhorna, J., & Marazziti, D. (2002). Do animal models of anxiety predict anxiolytic-like effects of antidepressants?Psychopharmacology (Berlin), 163, 121–141.
Drevets, W. C., Thase, M. E., Moses-Kolko, E. L., et al. (2007). Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nuclear Medicine and Biology, 34, 865–877.
Drugan, R. C., Ryan, S. M., Minor, T. R., & Maier, S. F. (1984). Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock. Pharmacology Biochemistry and Behavior, 21, 749–754.
Dulawa, S. C., & Hen, R. (2005). Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neuroscience and Biobehavioral Reviews, 29, 771–783.
Fava, M., Rush, A. J., Alpert, J. E., et al. (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry, 165, 342–351.
File, S. E. (1980). The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. Journal of Neuroscience Methods, 2, 219–238.
Frazer, A., & Morilak, D. A. (2005). What should animal models of depression model?Neuroscience and Biobehavioral Reviews, 29, 515–523.
Gambarana, C., Scheggi, S., Tagliamonte, A., Tolu, P., & De Montis, M. G. (2001). Animal models for the study of antidepressant activity. Brain Research. Brain Research Protocols, 7, 11–20.
Gardier, A. M., Malagie, I., Trillat, A. C., Jacquot, C., & Artigas, F. (1996). Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundamental and Clinical Pharmacology, 10, 16–27.
Gordon, J. W., Scangos, G. A., Plotkin, D. J., Barbosa, J. A., & Ruddle, F. H. (1980). Genetic transformation of mouse embryos by microinjection of purified DNA. Proceedingss of the National Academy of Sciences of the USA, 77, 7380–7384.
Gossen, M., & Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences of the USA, 89, 5547–5551.
Gottesman, I. I., & Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry, 160, 636–645.
Gross, C., Zhuang, X., Stark, K., et al. (2002). Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature, 416, 396–400.
Haller, J., Halasz, J., & Majercsik, E. (2004). Psychosocial conditions and the efficacy of clinically available anxiolytics. Current Drug Targets, 5, 655–664.
Heisler, L. K., Chu, H. M., Brennan, T. J., et al. (1998). Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proceedings of the National Academy of Sciences of the USA, 95, 15049–15054.
Hickman-Davis, J. M., & Davis, I. C. (2006). Transgenic mice. Paediatric Respiratory Reviews, 7, 49–53.
Jacob, H. J., & Kwitek, A. E. (2002). Rat genetics: attaching physiology and pharmacology to the genome. Nature Reviews Genetics, 3, 33–42.
Kalueff, A. V., & Murphy, D. L. (2007). The importance of cognitive phenotypes in experimental modeling of animal anxiety and depression. Neural Plasticity, 2007, 52087.
Klemenhagen, K. C., Gordon, J. A., David, D. J., Hen, R., & Gross, C. T. (2006). Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology, 31, 101–111.
Koponen, E., Voikar, V., Riekki, R., et al. (2004). Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Molecular and Cellular Neuroscience, 26, 166–181.
Lapiz-Bluhm, M. D., Bondi, C. O., Doyen, J., et al. (2008). Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. Journal of Neuroendocrinology, 20, 1115–1137.
Le Francois, B., Czesak, M., Steubl, D., & Albert, P. R. (2008). Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology, 55, 977–85.
Leonardo, E. D., & Hen, R. (2008). Anxiety as a developmental disorder. Neuropsychopharmacology, 33, 134–140.
Lister, R. G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin), 92, 180–185.
Lo Iacono, L., & Gross, C. (2008). Alpha-Ca2+/calmodulin-dependent protein kinase II contributes to the developmental programming of anxiety in serotonin receptor 1A knock-out mice. Journal of Neuroscience, 28, 6250–6257.
Lucki, I. (1997). The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behavioural Pharmacology, 8, 523–532.
Maren, S. (2001). Neurobiology of Pavlovian fear conditioning. Annual Review of Neuroscience, 24, 897–931.
McKinney, W. T. (1984). Animal models of depression: an overview. Psychiatric Development, 2, 77–96.
Melton, D. W. (1994). Gene targeting in the mouse. Bioessays, 16, 633–638.
Millan, M. J. (2003). The neurobiology and control of anxious states. Progress in Neurobiology, 70, 83–244.
Moret, C., & Briley, M. (2000). The possible role of 5-HT(1B/D) receptors in psychiatric disorders and their potential as a target for therapy. European Journal of Pharmacology, 404, 1–12.
Nemeroff, C. B. (2002). Comorbidity of mood and anxiety disorders: the rule, not the exception?American Journal of Psychiatry, 159, 3–4.
Nemeroff, C. B. (2003). Anxiolytics: past, present, and future agents. Journal of Clinical Psychiatry, 64 (Suppl. 3), 3–6.
Nesse, R. M. (1999). Proximate and evolutionary studies of anxiety, stress and depression: synergy at the interface. Neuroscience and Biobehavioral Reviews, 23, 895–903.
Ohl, F., Toschi, N., Wigger, A., Henniger, M. S., & Landgraf, R. (2001). Dimensions of emotionality in a rat model of innate anxiety. Behavioral Neuroscience, 115, 429–436.
Parks, C. L., Robinson, P. S., Sibille, E., Shenk, T., & Toth, M. (1998). Increased anxiety of mice lacking the serotonin1A receptor. Proceedings of the National Academy of Sciences of the USA, 95, 10734–10739.
Perry, J. L., & Carroll, M. E. (2008). The role of impulsive behavior in drug abuse. Psychopharmacology (Berlin), 200, 1–26.
Porter, R., Bock, G., Clark, S., & Ciba Foundation (1986). Antidepressants and Receptor Function. Chichester; New York, NY: Wiley.
Ramboz, S., Oosting, R., Amara, D. A., et al. (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences of the USA, 95, 14476–14481.
Ressler, K. J., & Nemeroff, C. B. (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety, 12 (Suppl. 1), 2–19.
Robbins, T. W. (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berlin), 163, 362–380.
Rodgers, R. J. (1997). Animal models of “anxiety”: where next?Behavioural Pharmacology, 8, 477–496; discussion 497–504.
Santarelli, L., Saxe, M., Gross, C., et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301, 805–809.
Serretti, A., Calati, R., Mandelli, L., & De Ronchi, D. (2006). Serotonin transporter gene variants and behavior: a comprehensive review. Current Drug Targets, 7, 1659–1669.
Sramek, J. J., Zarotsky, V., & Cutler, N. R. (2002). Generalised anxiety disorder: treatment options. Drugs, 62, 1635–1648.
Stark, K. L., Gross, C., Richardson-Jones, J., Zhuang, X., & Hen, R. (2007). A novel conditional knockout strategy applied to serotonin receptors. Handbook of Experimental Pharmacology, 178, 347–363.
van der Staay, F. J. (2006). Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy. Brain Research Reviews, 52, 131–159.
Weiss, J. M., Goodman, P. A., Losito, B. G., et al. (1981). Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Research Reviews, 3, 167–205.
Willner, P. (1997). Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berlin), 134, 319–329.
Willner, P., & Mitchell, P. J. (2002). The validity of animal models of predisposition to depression. Behavioural Pharmacology, 13, 169–188.
Zohar, J., Kennedy, J. L., Hollander, E., & Koran, L. M. (2004). Serotonin-1D hypothesis of obsessive–compulsive disorder: an update. Journal of Clinical Psychiatry, 65 (Suppl. 14), 18–21.

References

Amargos-Bosch, M., Bortolozzi, A., Puig, M. V., et al. (2004). Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cerebral Cortex, 14, 281–299.
Amargos-Bosch, M., Artigas, F., & Adell, A. (2005). Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex. European Journal of Pharmacology, 516, 235–238.
Amat, J., Baratta, M. V., Paul, E., et al. (2005). Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nature Neuroscience, 8, 365–371.
Amat, J., Paul, E., Zarza, C., Watkins, L. R., & Maier, S. F. (2006). Previous experience with behavioral control over stress blocks the behavioral and dorsal raphe nucleus activating effects of later uncontrollable stress: role of the ventral medial prefrontal cortex. Journal of Neuroscience, 26, 13264–13272.
Amat, J., Paul, E., Watkins, L. R., & Maier, S. F. (2008). Activation of the ventral medial prefrontal cortex during an uncontrollable stressor reproduces both the immediate and long-term protective effects of behavioral control. Neuroscience, 154, 1178–1186.
Ansorge, M. S., Zhou, M., Lira, A., Hen, R., & Gingrich, J. A. (2004). Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science, 306, 879–881.
Ansorge, M. S., Hen, R., & Gingrich, J. A. (2007). Neurodevelopmental origins of depressive disorders. Current Opinion in Pharmacology, 7, 8–17.
Araneda, R., & Andrade, R. (1991). 5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience, 40, 399–412.
Arango, V., Underwood, M. D., & Mann, J. J. (1997). Postmortem findings in suicide victims. Implications for in vivo imaging studies. Annals of the New York Academy of Sciences, 836, 269–287.
Arce, E., Simmons, A. N., Lovero, K. L., Stein, M. B., & Paulus, M. P. (2008). Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berlin), 196, 661–672.
Azmitia, E. C., Gannon, P. J., Kheck, N. M., & Whitaker-Azmitia, P. M. (1996). Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology, 14, 35–46.
Baratta, M. V., Christianson, J. P., Gomez, D. M., et al. (2007). Controllable versus uncontrollable stressors bi-directionally modulate conditioned but not innate fear. Neuroscience, 146, 1495–1503.
Beique, J. C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007). Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proceedingss of the National Academy of Sciences of the USA, 104, 9870–9875.
Bennett, A. J., Lesch, K. P., Heils, A., et al. (2002). Early experience and serotonin transporter gene variation interact to influence primate CNS function. Molecular Psychiatry, 7, 118–122.
Bevilaqua, L. R., Bonini, J. S., Rossato, J. I., et al. (2006). The entorhinal cortex plays a role in extinction. Neurobiology of Learning and Memory, 85, 192–197.
Bhagwagar, Z., Hinz, R., Taylor, M., et al. (2006). Increased 5-HT2A receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [11C]MDL 100,907. American Journal of Psychiatry, 163, 1580–1587.
Bishop, S., Duncan, J., Brett, M., & Lawrence, A. D. (2004). Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nature Neuroscience, 7, 184–188.
Bortolozzi, A., Amargos-Bosch, M., et al. (2003) In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs. European Journal of Neuroscience, 18, 1235–1246.
Bortolozzi, A., Diaz-Mataix, L., Scorza, M. C., Celada, P., & Artigas, F. (2005). The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. Journal of Neurochemistry, 95, 1597–1607.
Bruening, S., Oh, E., Hetzenauer, A., et al. (2006). The anxiety-like phenotype of 5-HT receptor null mice is associated with genetic background-specific perturbations in the prefrontal cortex GABA-glutamate system. Journal of Neurochemistry, 99, 892–899.
Burgos-Robles, A., Vidal-Gonzalez, I., Santini, E., & Quirk, G. J. (2007). Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron, 53, 871–880.
Cai, X., Gu, Z., Zhong, P., Ren, Y., & Yan, Z. (2002). Serotonin 5-HT1A receptors regulate AMPA receptor channels through inhibiting Ca2+/calmodulin-dependent kinase II in prefrontal cortical pyramidal neurons. Journal of Biological Chemistry, 277, 36553–36562.
Cameron, O. G., Huang, G. C., Nichols, T., et al. (2007) Reduced gamma-aminobutyric acidA-benzodiazepine binding sites in insular cortex of individuals with panic disorder. Archives of General Psychiatry, 64, 793–800.
Carroll, J. C., Boyce-Rustay, J. M., Millstein, R., et al. (2007). Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behavior Genetics, 37, 214–222.
Caspi, A., Sugden, K,. Moffitt, T. E., et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 301, 386–389.
Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001). Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABAA, and glutamate receptors. Journal of Neuroscience, 21, 9917–9929.
Celada, P., Puig, M., Amargos-Bosch, M., Adell, A., & Artigas, F. (2004). The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. Journal of Psychiatry and Neuroscience, 29, 252–265.
Celada, P., Puig, M. V., Diaz-Mataix, L., & Artigas, F. (2008). The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs. Biological Psychiatry, 64, 392–400.
Champoux, M., Bennett, A., Shannon, C., et al. (2002). Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Molecular Psychiatry, 7, 1058–1063.
Cheng, L. L., Wang, S. J., & Gean, P. W. (1998). Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors. European Journal of Neuroscience, 10, 2163–2172.
Corcoran, K. A., & Quirk, G. J. (2007). Activity in prelimbic cortex is necessary for the expression of learned, but not innate, fears. Journal of Neuroscience, 27, 840–844.
Cornea-Hebert, V., Riad, M., Wu, C., Singh, S. K., & Descarries, L. (1999). Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. Journal of Computational Neurology, 409, 187–209.
Crayton, J. W., Joshi, I., Gulati, A., Arora, R. C., & Wolf, W. A. (1996). Effect of corticosterone on serotonin and catecholamine receptors and uptake sites in rat frontal cortex. Brain Research, 728, 260–262.
Critchley, H. D., Wiens, S., Rotshtein, P., Ohman, A., & Dolan, R. J. (2004). Neural systems supporting interoceptive awareness. Nature Neuroscience, 7, 189–195.
Davis, M. (2004). Functional neuroanatomy of anxiety and fear. In D. S. Charney & E. J. Nestler, eds., Neurobiology of Mental Illness. Oxford: Oxford University Press.
Davis, M. (2006). Neural systems involved in fear and anxiety measured with fear-potentiated startle. American Psychologist, 61, 741–756.
Egner, T. (2008). Multiple conflict-driven control mechanisms in the human brain. Trends in Cognitive Science, 12, 374–380.
Etkin, A., Egner, T., Peraza, D. M., Kandel, E. R., & Hirsch, J. (2006). Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron, 51, 871–882.
Forster, G. L., Feng, N., Watt, M. J., et al. (2006). Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience, 141, 1047–1055.
Fox, M. A., Andrews, A. M., Wendland, J. R., et al. (2007). A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology (Berlin), 195, 147–166.
Frokjaer, V. G., Mortensen, E. L., Nielsen, F. Å., et al. (2008). Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biological Psychiatry, 63, 569–576.
Fuchs, E., & Flugge, G. (2004). Animal models of anxiety disorders. In D. S. Charney & E. J. Nestler, eds., Neurobiology of Mental Illness. Oxford: Oxford University Press.
Gilmartin, M. R., & McEchron, M. D. (2005). Single neurons in the medial prefrontal cortex of the rat exhibit tonic and phasic coding during trace fear conditioning. Behavioral Neuroscience, 119, 1496–1510.
Golimbet, V. E., Alfimova, M. V., & Mitiushina, N. G. (2004) [Polymorphism of the serotonin 2A receptor gene (5HTR2A) and personality traits]. Molecular Biology (Mosk), 38, 404–412.
Grahn, R. E., Will, M. J., Hammack, S. E., et al. (1999). Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor. Brain Research, 826, 35–43.
Griebel, G., Perrault, G., & Sanger, D. J. (1997). A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety. Neuropharmacology, 36, 793–802.
Gross, C., Santarelli, L., Brunner, D., Zhuang, X., & Hen, R. (2000). Altered fear circuits in 5-HT1A receptor KO mice. Biological Psychiatry, 48, 1157–1163.
Hariri, A. R., Mattay, V. S., Tessitore, A., et al. (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science, 297, 400–403.
Hariri, A. R., Mattay, V. S., Tessitore, A., Fera, F., & Weinberger, D. R. (2003). Neocortical modulation of the amygdala response to fearful stimuli. Biological Psychiatry, 53, 494–501.
Higley, J. D., Suomi, S. J., & Linnoila, M. (1991). CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys. Psychopharmacology (Berlin), 103, 551–556.
Holmes, A. (2008). Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neuroscience and Biobehavioral Reviews, 32, 1293–1314.
Holmes, A., Yang, R. J., Murphy, D. L., & Crawley, J. N. (2002). Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology, 27, 914–923.
Holmes, A., Lit, Q., Murphy, D. L., Gold, E., & Crawley, J. N. (2003a). Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes, Brain, and Behavior, 2, 365–380.
Holmes, A., Murphy, D. L., & Crawley, J. N. (2003b). Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biological Psychiatry, 54, 953–959.
Hoyer, D., & Martin, G. R. (1996). Classification and nomenclature of 5-HT receptors: a comment on current issues. Behavioural Brain Research, 73, 263–268.
Hoyer, D., Clarke, D. E., Fozard, J. R., et al. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacological Reviews, 46, 157–203.
Humphrey, P. P., Hartig, P., & Hoyer, D. (1993). A proposed new nomenclature for 5-HT receptors. Trends in Pharmacological Sciences, 14, 233–236.
Jacobs, B. L., & Azmitia, E. C. (1992). Structure and function of the brain serotonin system. Physiological Reviews, 72, 165–229.
Jakab, R. L., & Goldman-Rakic, P. S. (1998). 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proceedings of the National Academy of Sciences of the USA, 95, 735–740.
Kalueff, A. V., Fox, M. A., Gallagher, P. S., & Murphy, D. L. (2007). Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes, Brain, and Behavior, 6, 389–400.
Klemenhagen, K. C., Gordon, J. A., David, D. J., Hen, R., & Gross, C. T. (2006). Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology, 31, 101–111.
Koyama, S., Kubo, C., Rhee, J. S., & Akaike, N. (1999). Presynaptic serotonergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neurons. Journal of Physiology, 518, 525–538.
Koyama, S., Matsumoto, N., Murakami, N., et al. (2002). Role of presynaptic 5-HT1A and 5-HT3 receptors in modulation of synaptic GABA transmission in dissociated rat basolateral amygdala neurons. Life Sciences, 72, 375–387.
Krysiak, R., Obuchowicz, E., & Herman, Z. S. (2000) Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone. Neuropeptides, 34, 148–157.
Lambe, E. K., & Aghajanian, G. K. (2006). Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: role of glutamate spillover and NR2B-NMDA receptors. Neuropsychopharmacology, 31, 1682–1689.
Laviolette. S. R., Lipski, W. J., & Grace, A. A. (2005). A subpopulation of neurons in the medial prefrontal cortex encodes emotional learning with burst and frequency codes through a dopamine D4 receptor-dependent basolateral amygdala input. Journal of Neuroscience, 25, 6066–6075.
Lesch, K. P., Zeng, Y., Reif, A., & Gutknecht, L. (2003). Anxiety-related traits in mice with modified genes of the serotonergic pathway. European Journal of Pharmacology, 480, 185–204.
Li, X., Inoue, T., Abekawa, T., Weng, S., et al. (2006). 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala. European Journal of Pharmacology, 532, 74–80.
Lira, A,. Zhou, M., Castanon, N., et al. (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biological Psychiatry, 54, 960–971.
Maier, S. F., & Watkins, L. R. (2005). Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neuroscience and Biobehavioral Reviews, 29, 829–841.
Marek, G. J., & Aghajanian, G. K. (1998). 5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation. Neuroscience, 86, 485–497.
Marek, G. J., & Aghajanian, G. K. (1999). 5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. European Journal of Pharmacology, 367, 197–206.
Marek, G. J., Wright, R. A., Gewirtz, J. C., & Schoepp, D. D. (2001). A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience, 105, 379–392.
Marschner, A., Kalisch, R., Vervliet, B., Vansteenwegen, D., & Buchel, C. (2008). Dissociable roles for the hippocampus and the amygdala in human cued versus context fear conditioning. Journal of Neuroscience, 28, 9030–9036.
Martin-Ruiz, R., Puig, M. V., Celada, P., et al. (2001) Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. Journal of Neuroscience, 21, 9856–9866.
Mathew, S. J., Price, R. B., & Charney, D. S. (2008). Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. American Journal of Medical Genetics C: Seminars in Medical Genetics, 148C, 89–98.
Meyer, J. H., McMain, S., Kennedy, S. H., et al. (2003). Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. American Journal of Psychiatry, 160, 90–99.
Milad, M. R., Wright, C. I., Orr, S. P., et al. (2007). Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biological Psychiatry, 62, 446–454.
Millan, M. J. (2003). The neurobiology and control of anxious states. Progress in Neurobiology, 70, 83–244.
Miller, E. K., & Cohen, J. D. (2001). An integrative theory of prefrontal cortex function. Annual Review of Neuroscience, 24, 167–202.
Miner, L. A., Backstrom, J. R., Sanders-Bush, E., & Sesack, S. R. (2003). Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience, 116, 107–117.
Monk, C. S., Telzer, E. H., Mogg, K., et al. (2008). Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Archives of General Psychiatry, 65, 568–576.
Murphy, D. L., Li, Q., Engel, S., et al. (2001). Genetic perspectives on the serotonin transporter. Brain Research Bulletin, 56, 487–494.
Nash, J. R., Sargent, P. A., Rabiner, E. A., et al. (2008). Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. British Journal of Psychiatry, 193, 229–234.
Nitschke, J. B., Sarinopoulos, I., Mackiewicz, K. L., Schaefer, H. S., & Davidson, R. J. (2006). Functional neuroanatomy of aversion and its anticipation. Neuroimage, 29, 106–116.
Norton, N., & Owen, M. J. (2005). HTR2A: association and expression studies in neuropsychiatric genetics. Annals of Medicine, 37, 121–129.
Papez, J. W. (1995). A proposed mechanism of emotion. 1937. Journal of Neuropsychiatry and Clinical Neuroscience, 7, 103–112.
Parks, C. L., Robinson, P. S., Sibille, E., Shenk, T., & Toth, M. (1998). Increased anxiety of mice lacking the serotonin1A receptor. Proceedings of the National Academy of Sciences of the USA, 95, 10734–10739.
Paulus, M. P., & Stein, M. B. (2006). An insular view of anxiety. Biological Psychiatry, 60, 383–387.
Pehek, E. A., McFarlane, H. G., Maguschak, K., Price, B., & Pluto, C. P. (2001). M100,907, a selective 5-HT2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Research, 888, 51–59.
Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., et al. (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience, 8, 828–834.
Phelps, E. A., Delgado, M. R., Nearing, K. I., & LeDoux, J. E. (2004). Extinction learning in humans: role of the amygdala and vmPFC. Neuron, 43, 897–905.
Pompeiano, M., Palacios, J. M., & Mengod, G. (1992). Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. Journal of Neuroscience, 12, 440–453.
Puig, M. V., Celada, P., Diaz-Mataix, L., & Artigas, F. (2003). In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cerebral Cortex, 13, 870–882.
Quirk, G. J., & Mueller, D. (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology, 33, 56–72.
Quirk, G. J., Russo, G. K., Barron, J. L., & Lebron, K. (2000). The role of ventromedial prefrontal cortex in the recovery of extinguished fear. Journal of Neuroscience, 20, 6225–6231.
Quirk, G. J., Likhtik, E., Pelletier, J. G., & Pare, D. (2003). Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. Journal of Neuroscience, 23, 8800–8807.
Ramboz, S., Oosting, R., Amara, D. A., et al. (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences of the USA, 95, 14476–14481.
Rauch, S. L., Shin, L. M., & Phelps, E. A. (2006). Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research: past, present, and future. Biological Psychiatry, 60, 376–382.
Remijnse, P. L., Nielen, M. M., van Balkom, A. J., et al. (2006). Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive–compulsive disorder. Archives of General Psychiatry, 63, 1225–1236.
Ressler, K. J., & Mayberg, H. S. (2007). Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nature Neuroscience, 10, 1116–1124.
Risch, N., Herrell, R., Lehner, T., et al. (2009). Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA, 301, 2462–2471.
Rosenkranz, J. A., & Grace, A. A. (2002). Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. Journal of Neuroscience, 22, 324–337.
Santana, N., Bortolozzi, A., Serrats, J., Mengod, G., & Artigas, F. (2004). Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cerebral Cortex, 14, 1100–1109.
Sarinopoulos, I., Dixon, G. E., Short, S. J., Davidson, R. J., & Nitschke, J. B. (2006). Brain mechanisms of expectation associated with insula and amygdala response to aversive taste: implications for placebo. Brain, Behavior, and Immunity, 20, 120–132.
Serretti, A., Drago, A., & De Ronchi, D. (2007). HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Current Medicinal Chemistry, 14, 2053–2069.
Stein, C., Davidowa, H., & Albrecht, D. (2000). 5-HT1A receptor-mediated inhibition and 5-HT2 as well as 5-HT3 receptor-mediated excitation in different subdivisions of the rat amygdala. Synapse, 38, 328–337.
Stein, M. & Bienvenu, J. (2004). Diagnostic classification of anxiety disorders: DSM-5 and beyond. In D. S. Charney & E. J. Nestler, eds., Neurobiology of Mental Illness. Oxford: Oxford University Press.
Tipples, J., & Sharma, D. (2000). Orienting to exogenous cues and attentional bias to affective pictures reflect separate processes. British Journal of Psychology, 91, 87–97.
Tochigi, M., Umekage, T., Kato, C., et al. (2005). Serotonin 2A receptor gene polymorphism and personality traits: no evidence for significant association. Psychiatric Genetics, 15, 67–69.
Tork, I. (1990), Anatomy of the serotonergic system. Annals of the New York Academy of Sciences, 600, 9–34.
Torres, G. E., & Amara, S. G. (2007). Glutamate and monoamine transporters: new visions of form and function. Current Opinion in Neurobiology, 17, 304–312.
Tsetsenis, T., Ma, X. H., Lo Iacono, L., Beck, S. G., & Gross, C. (2007). Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus. Nature Neuroscience, 10, 896–902.
Unschuld, P. G., Ising, M., Erhardt, A., et al. (2007). Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B, 424–429.
Vollenweider, F. X., Vontobel, P., Hell, D., & Leenders, K. L. (1999). 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man: a PET study with 11Craclopride. Neuropsychopharmacology, 20, 424–433.
Vuilleumier, P. (2005). How brains beware: neural mechanisms of emotional attention. Trends in Cognitive Science, 9, 585–594.
Weisstaub, N. V., Zhou, M., Lira, A., et al. (2006). Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science, 313, 536–540.
Wright, C. I., Martis, B., McMullin, K., Shin, L. M., & Rauch, S. L. (2003). Amygdala and insular responses to emotionally valenced human faces in small animal specific phobia. Biological Psychiatry, 54, 1067–1076.
Zhao, S., Edwards, J., Carroll, J., Wiedholz, L., et al. (2006). Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience, 140, 321–334.

References

Adhikari, A., Topiwala, M.A., Gordon, J.A. (2010). Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety. Neuron, 65, 257–269.
Aguilar, R., Gil, L., Flint, J., et al. (2002). Learned fear, emotional reactivity and fear of heights: a factor analytic map from a large F2 intercross of Roman rat strains. Brain Research Bulletin, 57, 17–26.
Alheid, G. F., de Olmos, J. S., & Beltramino, C. A. (1995). Amygdala and extended amygdala. In G. Paxinos, ed., The Rat Nervous System. New York, NY: Academic Press.
Bagdy, G., Graf, M., Anheuer, Z. E., Modos, E. A., & Kantor, S. (2001). Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. International Journal of Neuropsychopharmacology, 4, 399–408.
Bannerman, D. M., Rawlins, J. N., McHugh, S. B., et al. (2004). Regional dissociations within the hippocampus: memory and anxiety. Neuroscience and Biobehavioral Review, 28, 273–283.
Belzung, C., & Griebel, G. (2001). Measuring normal and pathological anxiety-like behaviour in mice: a review. Behavioral Brain Research, 125, 141–149.
Berkowitz, R. L., Coplan, J. D., Reddy, D. P., & Gorman, J. M. (2007). The human dimension: how the prefrontal cortex modulates the subcortical fear response. Reviews in the Neurosciences, 18, 191–207.
Bourin, M., & Hascoet, M. (2003). The mouse light/dark box test. European Journal of Pharmacology, 463, 55–65.
Britton, D. R., & Britton, K. T. (1981). A sensitive open field measure of anxiolytic drug activity. Pharmacology, Biochemistry, and Behavior, 15, 577–582.
Burgos-Robles, A., Vidal-Gonzalez, I., Santini, E., & Quirk, G. J. (2007). Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron, 53, 871–880.
Burwell, R. D., & Witter, M. P. (2002). Basic anatomy of the parahippocampal region in monkeys and rats. In M. P. Witter & F. G. Wouterlood, eds., The Parahippocampal Region: Organization and Role in Cognitive Function. Oxford: Oxford University Press.
Burwell, R. D., Witter, M. P., & Amaral, D. G. (1995). Perirhinal and postrhinal cortices of the rat: a review of the neuroanatomical literature and comparison with findings from the monkey brain. Hippocampus, 5, 390–408.
Campeau, S., & Davis, M. (1995). Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. Journal of Neuroscience, 15, 2301–2311.
Crawley, J. N. (1985). Exploratory behavior models of anxiety in mice. Neuroscience and Biobehavioral Reviews, 9, 37–44.
Cruz, A. P., Frei, F., & Graeff, F. G. (1994). Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacology, Biochemistry, and Behavior, 49, 171–176.
Davis, M. (1992). The role of the amygdala in fear and anxiety. Annual Review of Neuroscience, 15, 353–375.
Davis, M. (1997). Neurobiology of fear responses: the role of the amygdala. Journal of Neuropsychiatry and Clinical Neuroscience, 9, 382–402.
de Angelis, L., & File, S. E. (1979). Acute and chronic effects of three benzodiazepines in the social interaction anxiety test in mice. Psychopharmacology (Berlin), 64, 127–129.
Dekeyne, A., Brocco, M., Adhumeau, A., Gobert, A., & Millan, M. J. (2000). The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats: a comparison with other anxiolytic agents. Psychopharmacology (Berlin), 152, 55–66.
Drapier, D., Bentue-Ferrer, D., Laviolle, B., et al. (2007). Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behavioral Brain Research, 176, 202–209.
Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R. (2004). Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology, 29, 1321–1330.
Durand, M., Berton, O., Aguerre, S., et al. (1999). Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis in shr and wky rats. Neuropharmacology, 38, 893–907.
Etkin, A., & Wager, T. D. (2007). Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry, 164, 1476–1488.
Falls, W. A., Miserendino, M. J., & Davis, M. (1992). Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. Journal of Neuroscience, 12, 854–863.
Fanselow, M. S., & Kim, J. J. (1994). Acquisition of contextual pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid to the basolateral amygdala. Behavioral Neuroscience, 108(1), 210–212.
File, S. E., & Hyde, J. R. (1979). A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. Pharmacology, Biochemistry, and Behavior, 11, 65–69.
File, S. E., & Seth, P. (2003). A review of 25 years of the social interaction test. European Journal of Pharmacology, 463, 35–53.
Garakani, A., Mathew, S. J., & Charney, D. S. (2006). Neurobiology of anxiety disorders and implications for treatment. Mount Sinai Journal of Medicine, 73, 941–949.
Gewirtz, J. C., & Davis, M. (1998). Application of Pavlovian higher-order conditioning to the analysis of the neural substrates of fear conditioning. Neuropharmacology, 37, 453–459.
Gonzalez, L. E., Rujano, M., Tucci, S., et al. (2000). Medial prefrontal transection enhances social interaction. I: Behavioral studies. Brain Research, 887, 7–15.
Gordon, J. A., & Hen, R. (2004). The serotonergic system and anxiety. Neuromolecular Medicine, 5, 27–40.
Gorman, J. M., Kent, J. M., & Coplan, J. D. (2002). Current and emerging therapeutics of anxiety and stress disorders. In K. L. Davis, D. S. Charney, J. T. Coyle, & C. Nemeroff, eds., Neuropsychopharmacology: the Fifth Generation of Progress. Philadelphia, PA: Lippincott Williams & Wilkins.
Green, S., & Vale, A. L. (1992). Role of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats. Behavioral Pharmacology, 3, 261–264.
Griebel, G., Moreau, J. L., Jenck, F., Misslin, R., & Martin, J. R. (1994). Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology (Berlin), 113, 463–470.
Griebel, G., Blanchard, D. C., & Blanchard, R. J. (1996). Evidence that the behaviors in the mouse defense test battery relate to different emotional states: a factor analytic study. Physiology and Behavior, 60, 1255–1260.
Griebel, G., Cohen, C., Perrault, G., & Sanger, D. J. (1999). Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats. Physiology and Behavior, 67, 315–320.
Grillon, C., Levenson, J., & Pine, D. S. (2007). A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology, 32, 225–231.
Guastella, A. J., Dadds, M. R., Lovibond, P. F., Mitchell, P., & Richardson, R. (2007). A randomized controlled trial of the effect of d-cycloserine on exposure therapy for spider fear. Journal of Psychiatric Research, 41, 466–471.
Guastella, A. J., Richardson, R., Lovibond, P. F., et al. (2008). A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biological Psychiatry, 63, 544–549.
Hitchcock, J. M., & Davis, M. (1991). Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behavioral Neuroscience, 105, 826–842.
Hofmann, S. G., Meuret, A. E., Smits, J. A., et al. (2006). Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Archives of General Psychiatry, 63, 298–304.
Hoover, W. B., & Vertes, R. P. (2007). Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Structure and Function, 212, 149–179.
Kantor, S., Graf, M., Anheuer, Z. E., & Bagdy, G. (2001). Rapid desensitization of 5-HT1A receptors in Fawn-Hooded rats after chronic fluoxetine treatment. European Neuropsychopharmacology, 11, 15–24.
Kjelstrup, K. G., Tuvnes, F. A., Steffenach, H. A., et al. (2002). Reduced fear expression after lesions of the ventral hippocampus. Proceedings of the National Academy of Sciences of the USA, 99, 10825–10830.
Kondo, Y., & Sakuma, Y. (2005). The medial amygdala controls the coital access of female rats: a possible involvement of emotional responsiveness. Japanese Journal of Physiology, 55, 345–353.
Kurt, M., Arik, A. C., & Celik, S. (2000). The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice. Journal of Basic Clinical Physiology and Pharmacology, 11, 173–180.
Kushner, M. G., Kim, S. W., Donahue, C., et al. (2007). D-cycloserine augmented exposure therapy for obsessive–compulsive disorder. Biological Psychiatry, 62, 835–838.
Lacroix, L., Spinelli, S., Heidbreder, C. A., & Feldon, J. (2000). Differential role of the medial and lateral prefrontal cortices in fear and anxiety. Behavioral Neuroscience, 114, 1119–1130.
LeDoux, J. (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23, 155–184.
LeDoux, J. (2003). The emotional brain, fear, and the amygdala. Cellular and Molecular Neurobiology, 23, 727–738.
McNamara, R. K., & Skeleton, R. W. (1993). Effects of intracranial infusions of chlordiazepoxide on spatial learning in the Morris water maze. I. Neuroanatomical specificity. Behavioral Brain Research, 59, 175–191.
Miserendino, M. J., Sananes, C. B., Melia, K. R., & Davis, M. (1990). Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature, 345, 716–718.
Moller, C., Wiklund, L., Sommer, W., Thorsell, A., & Heilig, M. (1997). Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Research, 760, 94–101.
Montgomery, K. C. (1955). The relation between fear induced by novel stimulation and exploratory behavior. Journal of Computational Physiology and Psychology, 48, 254–260.
Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008). A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry, 63, 1118–1126.
Pellow, S., & File, S. E. (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacology, Biochemistry and Behavior, 24, 525–529.
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14, 149–167.
Pesold, C., & Treit, D. (1995). The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Research, 671, 213–221.
Prut, L., & Belzung, C. (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology, 463, 3–33.
Quirk, G. J., & Beer, J. S. (2006). Prefrontal involvement in the regulation of emotion: convergence of rat and human studies. Current Opinion in Neurobiology, 16, 723–727.
Quirk, G. J., & Mueller, D. (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology, 33, 56–72.
Ramos, A., Berton, O., Mormede, P., & Chaouloff, F. (1997). A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behavioural Brain Research, 85, 57–69.
Rauch, S. L., Shin, L. M., & Phelps, E. A. (2006). Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research: past, present, and future. Biological Psychiatry, 60, 376–382.
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., et al. (2004). Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Archives General Psychiatry, 61, 1136–1144.
Rodgers, R. J. (1997). Animal models of “anxiety”: where next?Behavioral Pharmacology, 8, 477–496; discussion 497–504.
Roffman, J. L., Marci, C. D., Glick, D. M., Dougherty, D. D., & Rauch, S. L. (2005). Neuroimaging and the functional neuroanatomy of psychotherapy. Psychological Medicine, 35, 1385–1398.
Sanders, S. K., & Shekhar, A. (1995). Anxiolytic effects of chlordiazepoxide blocked by injection of GABAA and benzodiazepine receptor antagonists in the region of the anterior basolateral amygdala of rats. Biological Psychiatry, 37, 473–476.
Schienle, A., Schafer, A., Walter, B., Stark, R., & Vaitl, D. (2005). Brain activation of spider phobics towards disorder-relevant, generally disgust- and fear-inducing pictures. Neuroscience Letters, 388, 1–6.
Schmitt, U., & Hiemke, C. (1998). Combination of open field and elevated plus-maze: a suitable test battery to assess strain as well as treatment differences in rat behavior. Progress in Neuropsychopharmacology and Biological Psychiatry, 22, 1197–1215.
Seidenbecher, T., Laxmi, T. R., Stork, O., & Pape, H. C. (2003). Amygdalar and hippocampal theta rhythm synchronization during fear memory retrieval. Science, 301, 846–850.
Shah, A. A., & Treit, D. (2003). Excitotoxic lesions of the medial prefrontal cortex attenuate fear responses in the elevated-plus maze, social interaction and shock probe burying tests. Brain Research, 969, 183–194.
Siemiatkowski, M., Sienkiewicz-Jarosz, H., Czlonkowska, A. I., Bidzinski, A., & Plaznik, A. (2000). Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H]muscimol binding after buspirone pretreatment. Pharmacology, Biochemistry and Behavior, 66, 645–651.
Silva, R. C., & Brandao, M. L. (2000). Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacology, Biochemistry and Behavior, 65, 209–216.
Storch, E. A., Merlo, L. J., Bengtson, M., et al. (2007). D-cycloserine does not enhance exposure-response prevention therapy in obsessive–compulsive disorder. International Clinical Psychopharmacology, 22, 230–237.
Straube, T., Mentzel, H. J., & Miltner, W. H. (2007). Waiting for spiders: brain activation during anticipatory anxiety in spider phobics. Neuroimage, 37, 1427–1436.
To, C. T., & Bagdy, G. (1999). Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment. Neuropharmacology, 38, 279–282.
Treit, D., Aujla, H., & Menard, J. (1998). Does the bed nucleus of the stria terminalis mediate fear behaviors?Behavioral Neuroscience, 112, 379–386.
Veening, J. G., Swanson, L. W., & Sawchenko, P. E. (1984). The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study. Brain Research, 303, 337–357.
Vertes, R. P. (2004). Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse, 51, 32–58.
Walker, D. L., & Davis, M. (1997a). Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biological Psychiatry, 42, 461–471.
Walker, D. L., & Davis, M. (1997b). Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. Journal of Neuroscience, 17, 9375–9383.
Walker, D. L., & Davis, M. (2002). The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacology, Biochemistry and Behavior, 71, 379–392.
Walker, D. L., Ressler, K. J., Lu, K. T., & Davis, M. (2002). Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. Journal of Neuroscience, 22, 2343–2351.
Whishaw, I. Q., Gharbawie, O. A., Clark, B. J., & Lehmann, H. (2006). The exploratory behavior of rats in an open environment optimizes security. Behavioral Brain Research, 171, 230–239.
Wilhelm, S., Buhlmann, U., Tolin, D. F., et al. (2008). Augmentation of behavior therapy with d-cycloserine for obsessive–compulsive disorder. American Journal of Psychiatry, 165, 335–341; quiz 409.
Zangrossi Junior, H., & Graeff, F. G. (1994). Behavioral effects of intra-amygdala injections of GABA and 5-HT acting drugs in the elevated plus-maze. Brazilian Journal of Medical and Biological Research, 27, 2453–2456.

References

American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
Bandler, R., & Shipley, M. T. (1994). Columnar organization in the midbrain periaqueductal gray: modules for emotional expression?Trends in Neuroscience, 17, 379–389.
Baxter, L. R., Schwartz, J. M., Bergman, K. S., et al. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive–compulsive disorder. Archives of General Psychiatry, 49, 681–689.
Behbehani, M. M. (1995). Functional characteristics of the midbrain periaqueductal gray. Progress in Neurobiology, 46, 575–605.
Bishop, S. J., Duncan, J., & Lawrence, A. D. (2004). State anxiety modulation of the amygdala response to unattended threat-related stimuli. Journal of Neuroscience, 24, 10364–10368.
Botvinick, M., Nystrom, L. E., Fissell, K., Carter, C. S., & Cohen, J. D. (1999). Conflict monitoring versus selection-for-action in anterior cingulate cortex. Nature, 402, 179–181.
Bryant, R. A., Kemp, A. H., Felmingham, K. L., et al. (2008a). Enhanced amygdala and medial prefrontal activation during nonconscious processing of fear in posttraumatic stress disorder: an fMRI study. Human Brain Mapping, 29, 517–523.
Bryant, R. A., Felmingham, K., Kemp, A., et al. (2008b). Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychology and Medicine, 38, 555–561.
Buchel, C., & Dolan, R. J. (2000). Classical fear conditioning in functional neuroimaging. Current Opinions in Neurobiology, 10, 219–223.
Buckner, R. L., & Carroll, D. C. (2007). Self-projection and the brain. Trends in Cognitive Sciences, 11, 49–57.
Corcoran, K. A., Desmond, T. J., Frey, K. A., & Maren, S. (2005). Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction. Journal of Neuroscience, 25, 8978–8987.
Courtney, S. M., Ungerleider, L. G., Keil, K., & Haxby, J. V. (1997). Transient and sustained activity in a distributed neural system for human working memory. Nature, 386, 608–611.
Critchley, H. D., Wiens, S., Rotshtein, P., Ohman, A., & Dolan, R. J. (2004). Neural systems supporting interoceptive awareness. Nature Neuroscience, 7, 189–195.
Delgado, M. R., Nearing, K. I., Ledoux, J. E., & Phelps, E. A. (2008). Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron, 59, 829–838.
D’Esposito, M., Postle, B. R., & Rypma, B. (2000). Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies. Experimental Brain Research, 133, 3–11.
Egner, T., & Hirsch, J. (2005a). Cognitive control mechanisms resolve conflict through cortical amplification of task-relevant information. Nature Neuroscience, 8, 1784–1790.
Egner, T., & Hirsch, J. (2005b). The neural correlates and functional integration of cognitive control in a Stroop task. Neuroimage, 24, 539–547.
Egner, T., Etkin, A., Gale, S., & Hirsch, J. (2008). Dissociable neural systems resolve conflict from emotional versus nonemotional distracters. Cerebral Cortex, 18, 1475–1484.
Eisenberg, M., Kobilo, T., Berman, D. E., & Dudai, Y. (2003). Stability of retrieved memory: inverse correlation with trace dominance. Science, 301, 1102–1104.
Etkin, A., & Wager, T. D. (2007). Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry, 164, 1476–1488.
Etkin, A., Klemenhagen, K. C., Dudman, J. T., et al. (2004). Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron, 44, 1043–1055.
Etkin, A., Pittenger, C., Polan, H. J., & Kandel, E. R. (2005). Toward a neurobiology of psychotherapy: basic science and clinical applications. Journal of Neuropsychiatry and Clinical Neuroscience, 17, 145–158.
Etkin, A., Egner, T., Peraza, D. M., Kandel, E. R., & Hirsch, J. (2006). Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron, 51, 871–882.
Furmark, T., Tillfors, M., Marteinsdottir, I., et al. (2002). Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive–behavioral therapy. Archives of General Psychiatry, 59, 425–433.
Gabbott, P. L., Warner, T. A., Jays, P. R., Salway, P., & Busby, S. J. (2005). Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. Journal of Computational Neurology, 492, 145–177.
Gratton, G., Coles, M. G., & Donchin, E. (1992). Optimizing the use of information: strategic control of activation of responses. Journal of Experimental Psychology: General, 121, 480–506.
Gross, J. J. (1998). The emerging field of emotion regulation: an integrative review. Review of General Psychology, 2, 271–299.
Gusnard, D. A., & Raichle, M. E. (2001). Searching for a baseline: functional imaging and the resting human brain. Nature Reviews Neuroscience, 2, 685–694.
Kalisch, R., Korenfeld, E., Stephan, K. E., et al. (2006). Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. Journal of Neuroscience, 26, 9503–9511.
Karl, A., Schaefer, M., Malta, L. S., et al. (2006). A meta-analysis of structural brain abnormalities in PTSD. Neuroscience and Biobehavioral Review, 30, 1004–1031.
Kasai, K., Yamasue, H., Gilbertson, M. W., et al. (2008). Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biological Psychiatry, 63, 550–556.
Kerns, J. G., Cohen, J. D., MacDonald, A. W., et al. (2004). Anterior cingulate conflict monitoring and adjustments in control. Science, 303, 1023–1026.
Kim, J. J., Rison, R. A., & Fanselow, M. S. (1993). Effects of amygdala, hippocampus, and periaqueductal gray lesions on short-and long-term contextual fear. Behavioral Neuroscience, 107, 1093–1098.
Kober, H., Barrett, L. F., Joseph, J., et al. (2008). Functional grouping and cortical-subcortical interactions in emotion: A meta-analysis of neuroimaging studies. Neuroimage, 42, 998–1031.
Kringelbach, M. L., & Rolls, E. T. (2004). The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Progress in Neurobiology, 72, 341–372.
LaBar, K. S., Gatenby, J. C., Gore, J. C., LeDoux, J. E., & Phelps, E. A. (1998). Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron, 20, 937–945.
Lanius, R. A., Williamson, P. C., Hopper, J., et al. (2003). Recall of emotional states in posttraumatic stress disorder: an fMRI investigation. Biological Psychiatry, 53, 204–210.
Maren, S., Aharonov, G., & Fanselow, M. S. (1997). Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behavioral Brain Research, 88, 261–274.
Milad, M. R., & Quirk, G. J. (2002). Neurons in medial prefrontal cortex signal memory for fear extinction. Nature, 420, 70–74.
Milad, M. R., Vidal-Gonzalez, I., & Quirk, G. J. (2004). Electrical stimulation of medial prefrontal cortex reduces conditioned fear in a temporally specific manner. Behavioral Neuroscience, 118, 389–394.
Milad, M. R., Wright, C. I., Orr, S. P., et al. (2007). Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biological Psychiatry, 62, 446–454.
Nee, D. E., Wager, T. D., & Jonides, J. (2007). Interference resolution: Insights from a meta-analysis of neuroimaging tasks. Cognitive, Affective, and Behavioral Neuroscience, 7, 1–17.
Northoff, G., Heinzel, A., de Greck, M., et al. (2006). Self-referential processing in our brain: a meta-analysis of imaging studies on the self. Neuroimage, 31, 440–457.
Ochsner, K. N., & Gross, J. J. (2005). The cognitive control of emotion. Trends in Cognitive Sciences, 9, 242–249.
Ochsner, K. N., & Gross, J. J. (2008). Cognitive emotion regulation: Insights from social cognitive and affective neuroscience. Current Directions in Psychological Science, 17, 153–158.
Paxinos, G. (2003). The Human Nervous System, 2nd edn. San Diego, CA: Academic Press.
Phan, K. L., Wager, T., Taylor, S. F., & Liberzon, I. (2002). Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage, 16, 331–348.
Phan, K. L., Britton, J. C., Taylor, S. F., Fig, L. M., & Liberzon, I. (2006). Corticolimbic blood flow during nontraumatic emotional processing in posttraumatic stress disorder. Archives of General Psychiatry, 63, 184–192.
Phelps, E. A., Delgado, M. R., Nearing, K. I., & LeDoux, J. E. (2004). Extinction learning in humans: role of the amygdala and vmPFC. Neuron, 43, 897–905.
Quirk, G. J., Russo, G. K., Barron, J. L., & Lebron, K. (2000). The role of ventromedial prefrontal cortex in the recovery of extinguished fear. Journal of Neuroscience, 20, 62256231.
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., et al. (2001). A default mode of brain function. Proceedings of the National Academy of Sciences of the USA, 98, 676–682.
Rauch, S. L., Whalen, P. J., Shin, L. M., et al. (2000). Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biological Psychiatry, 47, 769–776.
Schienle, A., Schafer, A., Hermann, A., Rohrmann, S., & Vaitl, D. (2007). Symptom provocation and reduction in patients suffering from spider phobia: an fMRI study on exposure therapy. European Archives of Psychiatry and Clinical Neuroscience, 257, 486–493.
Shin, L. M., Whalen, P. J., Pitman, R. K., et al. (2001). An fMRI study of anterior cingulate function in posttraumatic stress disorder. Biological Psychiatry, 50, 932–942.
Shin, L. M., Wright, C. I., Cannistraro, P. A., et al. (2005). A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Archives of General Psychiatry, 62, 273–281.
Simmons, A., Stein, M. B., Matthews, S. C., Feinstein, J. S., & Paulus, M. P. (2006). Affective ambiguity for a group recruits ventromedial prefrontal cortex. Neuroimage, 29, 655–661.
Straube, T., Glauer, M., Dilger, S., Mentzel, H. J., & Miltner, W. H. (2006). Effects of cognitive–behavioral therapy on brain activation in specific phobia. Neuroimage, 29, 125–135.
Tillfors, M., Furmark, T., Marteinsdottir, I., et al. (2001). Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. American Journal of Psychiatry, 158, 1220–1226.
Vertes, R. P. (2004). Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse, 51, 32–58.
Wager, T. D., & Smith, E. E. (2003). Neuroimaging studies of working memory: a metaanalysis. Cognitive, Affective, and Behavioral Neuroscience, 3, 255–274.
Wager, T. D., Barrett, L. F., Bliss-Moreau, E., et al. (2008a). The neuroimaging of emotion. In M. Lewis, J. M. Haviland-Jones, & L. F. Barrett, eds., Handbook of Emotions, 3rd edn. New York, NY: Guilford Press.
Wager, T. D., Hughes, B., Davidson, M., Lindquist, M. L., & Ochsner, K. N. (2008b). Prefrontal–subcortical pathways mediating successful emotion regulation. Neuron, 59, 1037–1050.
Whalen, P. J., Kagan, J., Cook, R. G., et al. (2004). Human amygdala responsivity to masked fearful eye whites. Science, 306, 2061.
Whalen, P. J., Johnstone, T., Somerville, L. H., et al. (2008). A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biological Psychiatry, 63, 858–863.
Williams, L. M., Kemp, A. H., Felmingham, K., et al. (2006). Trauma modulates amygdala and medial prefrontal responses to consciously attended fear. Neuroimage, 29, 347–357.
Wright, C. I., Martis, B., McMullin, K., Shin, L. M., & Rauch, S. L. (2003). Amygdala and insular responses to emotionally valenced human faces in small animal specific phobia. Biological Psychiatry, 54, 1067–1076.
Yamasue, H., Kasai, K., Iwanami, A., et al. (2003). Voxel-based analysis of MRI reveals anterior cingulate gray-matter volume reduction in posttraumatic stress disorder due to terrorism. Proceedings of the National Academy of Sciences of the USA, 100, 9039–9043.

References

Abramowitz, J. S., Foa, E. B., & Franklin, M. E. (2003). Exposure and ritual prevention for obsessive–compulsive disorder: effects of intensive versus twice-weekly sessions. Journal of Consulting and Clinical Psychology, 71, 394–398.
Achenbach, T. M., Krukowski, R. A., Dumenci, L., & Ivanova, M. Y. (2005). Assessment of adult psychopathology: meta-analyses and implications of cross-informant correlations. Psychological Bulletin, 131, 361–382.
Albano, A. M., & Silverman, W. K. (1996). The Anxiety Disorders Interview Schedule for Children for DSM-IV: (Child and Parent Versions): Clinician’s Manual. New York, NY: Oxford University Press.
Albano, A. M., Chorpita, B. F., & Barlow, D. H. (2003). Anxiety disorders. In E.J. Mash & R.A. Barkley, eds., Child Psychopathology, 2nd edn. New York, NY: Guilford Press.
Barlow, D. H. (1988). Anxiety and its Disorders. New York, NY: Guilford Press.
Barlow, D. H., ed. (2001). Clinical Handbook of Psychological Disorders, 3rd edn. New York, NY: Guilford Press.
Barlow, D. H. (2002). Anxiety and its Disorders, 2nd edn. New York, NY: Guilford Press.
Barrios, B. A., & Hartmann, D. (1984). Fears and anxieties. In E. J. Mash & L. G. Terdal, eds., Behavioral Assessment of Childhood Disorders. New York, NY: Guilford Press.
Beck, A. T. (1967). Depression: causes and treatment. Philadelphia, PA: University of Pennsylvania Press.
Bitran, S., Morissette, S. B., Spiegel, D. A., & Barlow, D. H. (2008). A pilot study of sensation-focused intensive treatment for panic disorder with moderate to severe agoraphobia: preliminary outcome and benchmarking data. Behavior Modification, 32, 196–214.
Borkovec, T. D. (1994). The nature, functions, and origins of worry. In G. Davey & F. Tallis, eds., Worrying: Perspectives on Theory, Assessment, and Treatment. New York, NY: Wiley.
Borkovec, T. D., & Inz, J. (1990). The nature of worry in generalized anxiety disorder: a preponderance of thought activity. Behaviour Research and Therapy, 28, 153–158.
Bouton, M. E. (1993). Context, time and memory retrieval in the interference paradigms of Pavlovian learning. Psychological Bulletin, 114, 90–99.
Bouton, M. E. (2007). Learning and Behaviour: a Contemporary Synthesis. Sunderland, MA: Sinauer Associates.
Brewin, C. R., Dalgleish, T., & Joseph, S. (1996). A dual representation theory of posttraumatic stress disorder. Psychological Review, 103, 670–686.
Brown, T. A., O’Leary, T., & Barlow, D. H. (2001). Generalized anxiety disorder. In D.H. Barlow, ed., Clinical Handbook of Psychological Disorders, 3rd edn. New York, NY: Guilford Press.
Chorpita, B. F., & Barlow, D. H. (1998). The development of anxiety: the role of control in the early environment. Psychological Bulletin, 124, 3–21.
Choudhury, M. S., Pimentel, S. S., & Kendall, P. C. (2003). Childhood anxiety disorders: parent–child (dis)agreement using a structured interview for the DSM-IV. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 957–964.
Clark, D. M., Ehlers, A., Hackman, A., et al. (2006). Cognitive therapy versus exposure and applied relaxation in social phobia: a randomized controlled trial. Journal of Consulting and Clinical Psychology, 75, 568–578.
Comer, J. S., & Kendall, P. C. (2004). A symptom-level examination of parent–child agreement in the diagnosis of anxious youths. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 878–886.
Craske, M. G., Kircanski, K., Zelikowsky, M., et al. (2008). Optimizing inhibitory learning during exposure therapy. Behaviour Research and Therapy, 46, 5–27.
Davis, M., Montgomery, I., & Wilson, G. (2002). Worry and heart rate variables: autonomic rigidity under challenge. Journal of Anxiety Disorders, 16, 639–659.
Deacon, B. J., & Abramowitz, J. S. (2004). Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings. Journal of Clinical Psychology, 60, 429–441.
De Los Reyes, A., & Kazdin, A. E. (2005). Informant discrepancies in the assessment of childhood psychopathology: a critical review, theoretical framework, and recommendations for further study. Psychological Bulletin, 131, 483–509.
De Los Reyes, A., & Kazdin, A. E. (2006). Conceptualizing changes in behavior in intervention research: the range of possible changes model. Psychological Review, 113, 554–583.
Eelen, P., & Vervliet, B. (2006). Fear conditioning and clinical implications: what can we learn from the past? In M. G. Craske, D. Hermans, & D. Vansteenwegen, eds., Fear and Learning. Washington, DC, American Psychological Association, pp. 17–35.
Ellis, A. (1962). Reason and Emotion in Psychotherapy. Secaucus, NJ: Citadel.
Eysenck, H. J. (1952). The effects of psychotherapy: an evaluation. Journal of Consulting Psychology, 16, 319–324.
Gohm, C. L. (2003). Mood regulation and emotional intelligence: individual differences. Journal of Personality and Social Psychology, 84, 594–607.
Gohm, C. L., & Clore, G. L. (2002). Four latent traits of emotional experience and their involvement in well-being, coping, and attributional state. Cognition and Emotion, 16, 495–518.
Gray, J. A., & McNaughton, N. (1996). The neuropsychology of anxiety: reprise. In D. A. Hope, ed., Perspectives on Anxiety, Panic and Fear. Lincoln, NE: University of Nebraska Press.
Horvath, A. O., & Symonds, B. S. (1991). Relation between working alliance and outcome in psychotherapy: a meta-analysis. Journal of Counseling Psychology, 38, 139–149.
Jones, M. C. (1924). A laboratory study of fear: the case of Peter. Pedagogical Seminary, 31, 308–315.
Kazdin, A. E. (2006). Arbitrary metrics: implications for identifying evidence-based treatments. American Psychologist, 61, 42–49.
Kendall, P. C., ed. (2005). Child and Adolescent Therapy: Cognitive Behavioral Procedures, 3rd edn. New York, NY: Guilford Press.
Kendall, P. C., & Hollon, S. D., eds. (1979). Cognitive–behavioral Interventions: theory, research, and procedures. New York, NY: Academic Press.
Kendall, P. C., Comer, J. S., Marker, C. D., et al. (2009). In-session exposure tasks and therapeutic alliance across the treatment of childhood anxiety disorders. Journal of Consulting and Clinical Psychology, 77, 517–525.
Larsen, R. J., & Diener, E. (1987). Affect intensity as an individual difference characteristic: a review. Journal of Research in Personality, 21, 1–39.
Mahoney, M. J. (1974). Cognition and Behavior Modification. Cambridge, MA: Ballinger.
Martin, D. J., Garske, J. P., & Davis, M. K. (2000). Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. Journal of Consulting and Clinical Psychology, 68, 438–450.
Meichenbaum, D. (1977). Cognitive–Behavior Modification: an Integrative Approach. New York, NY: Plenum.
Mennin, D. S. (2004). Emotion regulation therapy for generalized anxiety disorder. Clinical Psychology and Psychotherapy, 11, 17–29.
Mennin, D. S., Heimberg, R. G., Turk, C. L., & Fresco, D. M. (2002). Applying an emotion regulation framework to integrative approaches to generalized anxiety disorder. Clinical Psychology: Science and Practice, 9, 85–90.
Mennin, D. S., Heimberg, R. G., Turk, C. L., & Fresco, D. M. (2005). Preliminary evidence for an emotion dysregulation model of generalized anxiety disorder. Behaviour Research and Therapy, 43, 1281–1310.
Mogg, K., Bradley, B., Williams, R., & MathewsA. (1993). Subliminal processing of emotional information in anxiety and depression. Journal of Abnormal Psychology, 102, 304–311.
Mowrer, O. H. (1947). On the dual nature of learning: A reinterpretation of “conditioning” and “problem solving”. Harvard Educational Review, 17, 102–148.
Myers, K. M., & Davis, M. (2007). Mechanisms of fear extinction. Molecular Psychiatry, 12, 120–150.
O’Donohue, W., & Krasner, L. (1995). Theories of Behavior Therapy: Exploring Behavior Change. Washington, DC: American Psychological Association Press.
Pine, D. S., Helfinstein, S. M., Bar-Haim, Y., Nelson, E., & Fox, N. A. (2008). Challenges in developing novel treatments for childhood disorders: lessons from research on anxiety. Neuropsychopharmacology Reviews, 1–16.
Roth, A., & Fonagy, P. (2004). What Works for Whom? A Critical Review of Psychotherapy Research, 2nd edn. New York, NY: Guilford Press.
Rowe, M. K., & Craske, M. G. (1998). Effects of an expanding-spaced vs. massed exposure on fear reduction and return of fear. Behaviour Research and Therapy, 36, 701–717.
Storch, E. A., Merlo, L. J., Lehmkuhl, H., et al. (2008). Cognitive–behavioral therapy for obsessive–compulsive disorder: a non-randomized comparison of intensive and weekly approaches. Journal of Anxiety Disorders, 22, 1146–1158.
Tsao, J. C. I., & Craske, M. G. (2000). Timing of treatment and return of fear: effects of massed, uniform-, and expanding-spaced exposure schedules. Behavior Therapy, 31, 479–497.
Turk, C. L., Heimberg, R.G., Luterek, J.A., Mennin, D.S., & Fresco, D.M. (2005). Delineating emotion regulation deficits in generalized anxiety disorder: a comparison with social anxiety disorder. Cognitive Therapy and Research, 29, 89–106.
Watson, J., & Raynor, R. (1920). Conditioned emotional reactions. Journal of Genetic Psychology, 37, 394–419.

References

American Psychiatric Association (1952). Diagnostic and Statistical Manual of Mental Disorders (DSM-I). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1968). Diagnostic and Statistical Manual of Mental Disorders, 2nd edn (DSM-II). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn (DSM-III). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn., revised (DSM-III-R). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington, DC: American Psychiatric Association.
Bodkin, J. A., Pope, H. G., Detke, M. J., & Hudson, J. I. (2007). Is PTSD caused by traumatic stress?Journal of Anxiety Disorders, 21, 176–182.
Breslau, N. (2002). Epidemiologic studies of trauma, posttraumatic stress disorder, and psychiatric disorders. Canadian Journal of Psychiatry, 47, 923–929.
Breslau, N., & Davis, G. C., (1987). Posttraumatic stress disorder: The stressor criterion. Journal of Nervous and Mental Disease, 175, 255–264.
Breslau, N., & Kessler, R. C. (2001). The stressor criterion in DSM-IV posttraumatic stress disorder: An empirical investigation. Biological Psychiatry, 50, 699–704.
Breslau, N., Davis, G. C., Andreski, P., & Peterson, E. (1991). Traumatic events and posttraumatic stress disorder in an urban population of young adults. Archives of General Psychiatry, 48, 216–222.
Dohrenwend, B. P. (1979). Stressful life events and psychopathology: some issues of theory and method. In J. F. Barrett, R. M. Rose, & G. L. Klerman, eds., Stress and Mental Disorder. New York, NY: Raven Press.
Dohrenwend, B. P. (1998). Theoretical integration. In B. P. Dohrenwend, ed., Adversity, Stress and Psychopathology. New York, NY: Oxford University Press.
Dohrenwend, B. P. (2000). The role of adversity and stress in psychopathology: some evidence and its implications for theory and research. Journal of Health and Social Behavior, 41, 1–19.
Dohrenwend, B. P. (2006). Inventorying stressful life events as risk factors for psychopathology: toward resolution of the problem of intracategory variability. Psychological Bulletin, 132, 477–495.
Dohrenwend, B.P., Turner, J.B., Turse, N.A., et al. (2006). The psychological risks of Vietnam for U.S. veterans: a revisit with new data and methods. Science, 313, 979–982.
Engdahl, B.Dikel, M. A, Eberly, R., & Blank, A. (1997). Posttraumatic stress disorder in a community group of former prisoners of war: a normative response to severe stress. American Journal of Psychiatry, 154, 1576–1581.
Erwin, B. A., Heimberg, R. G., Marx, B. P., Franklin, M. E. (2006). Traumatic and socially stressful life events among persons with social anxiety disorder. Journal of Anxiety Disorders, 20, 896–914.
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1996). Structured Clinical Interview for DSM-IV Axis I Disorders. New York, NY: New York State Psychiatric Institute.
Foa, E. B., Cashman, L., Jaycox, L., & Perry, K. (1997). The validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychological Assessment, 9, 445–451.
Friedman, M. J. (2005). Veterans’ mental health in the wake of war. New England Journal of Medicine, 352, 1287–1290.
Friedman, M. J., Resick, P. A., & Keane, T. M. (2007a). PTSD twenty-five years of progress and challenges. In M. J. Friedman, T. M. Keane, & P. A. Resick, eds., Handbook of PTSD: Science and Practice. New York, NY: Guilford Press.
Friedman, M. J., Resick, P. A., & Keane, T. M. (2007b). Key questions and an agenda for future research. In M. J. Friedman, T. M. Keane, & P. A. Resick, eds., Handbook of PTSD: Science and Practice. New York, NY: Guilford Press.
Gold, S. D., Marx, B. P., Soler-Baillo, J. M., & Loan, D. M. (2005). Is life stress more traumatic than traumatic stress?Journal of Anxiety Disorders, 19, 687–698.
Goodman, L. A., Corcoran, C., Turner, K., Yuan, N., & Green, B. (1998). Assessing traumatic event exposure: general issues and preliminary findings for the Stressful Life Events Screening Questionnaire. Journal of Traumatic Stress, 11, 521–542.
Hammen, C. (1991). Generation of stress in the course of unipolar depression. Journal of Abnormal Psychology, 100, 555–561.
Helzer, J. E., Robins, L. N., & McEvoy, L. (1987). Post-traumatic stress disorder in the general populaton: findings of the Epidemiologic Catchment Area Survey. New England Journal of Medicine, 417, 1630–1634.
Horowitz, M. J. (1978). Stress Response Syndromes. Northvale, NJ: Jason Aronson.
Horowitz, M. J. (1986). Stress Response Syndromes, 2nd edn. Northvale, NJ: Jason Aronson.
Horowitz, M. J., Winer, N., & Alvarez, W. (1979). Impact of Event Scale: a measure of subjective stress. Psychosomatic Medicine, 41, 209–218.
Hovens, J. E., & van der Ploeg, H. M. (1993). Post-traumatic stress disorder in Dutch psychiatric inpatients. Journal of Traumatic Stress, 6, 91–101.
Keane, T. M., Malloy, P. F., & Fairbank, J. A. (1984). Empirical development of an MMPI subscale for the assessment of combat-related posttraumatic stress disorder. Journal of Clinical and Consulting Psychology, 52, 888–891.
Keane, T. M., Caddel, J. M., & Taylor, K. L. (1988). Mississippi scale for combat-related posttraumatic stress disorder: three studies in reliability and validity. Journal of Clinical and Consulting Psychology, 56, 85–90.
Kendler, K. S., & Baker, J. H. (2007). Genetic influences on measures of the environment. Psychological Medicine, 37, 615–626.
Kessler, R. C., Sonnega, A., Bromet, E., & Nelson, C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52, 1048–60.
Kilpatrick, D. G., Resnick, H. S., Freedy, J. R., et al. (1998). Posttraumatic stress disorder field trial: evaluation of the PTSD construct. Criteria A through E. In T. Widiger, A. J. Frances, H. A. Pincus, et al., eds., DSM Sourcebook, Volume 4. Washington, DC: American Psychiatric Association.
Long, M. E., Elhai, J. D., Schweinle, A., et al. (2008). Differences in posttraumatic stress disorder diagnostic rates and symptom severity between Criterion A1 and non-Criterion A1 stressors. Journal of Anxiety Disorders, 22, 1255–1263.
Maier, T. (2007). Weathers’ and Keane’s “The Criterion A problem revisited: controversies and challenges in defining and measuring psychological trauma”. Journal of Traumatic Stress, 20, 915–916.
Maslow, A. H. (1954). Motivation and Personality. New York, NY: Harper.
McNally, R. J. (2003). Progress and controversy in the study of posttraumatic stress disorder. Annual Review of Psychology, 54, 229–252.
Mol, S. S. L., Arntz, A., Metsemakers, J. F. M., et al. (2005). Symptoms of post-traumatic stress disorder after non-traumatic events: evidence from an open population study. British Journal of Psychiatry, 186, 494–499.
Olff, M., Koeter, M. W. J., Van Haaften, E. H., Kersten, P. H., & Gersons, B. P. R. (2005). Impact of foot and mouth disease crisis on post-traumatic stress symptoms in farmers. British Journal of Psychiatry, 186, 165–166.
Rahe, R. H. (1988). Acute versus chronic reactions to combat. Military Medicine, 153, 365–372.
Robins, L. N., Helzer, J. E., Croughan, J., & Ratcliff, K. S. (1981). The Diagnostic Interview Schedule: Its history, characteristics, and validity. Archives of General Psychiatry, 38, 318–389.
Rona, R. J., Fear, N. T., Hull, L., Greenberg, N., et al. (2007). Mental health consequences of overstretch in UK armed forces: first phase of a cohort study. BMJ, 335, 604–609.
Rubin, D. C., Berntsen, D., & Bohni, M. K. (2008). A memory-based model of posttraumatic stress disorder: evaluating basic assumptions underlying the PTSD diagnosis. Psychological Review, 115, 985–1011.
Sarason, I., Johnson, J., & Siegel, J. (1978). Assessing the impact of life changes: development of the life experiences survey. Journal of Consulting and Clinical Psychology, 46, 932–946.
Schlenger, W. E., Caddell, J. M., Ebert, L., et al. (2002). Psychological reactions to terrorist attacks: findings from the National Study of Americans’ Reactions to September 11. JAMA, 288, 581–588.
Seidler, G. H., & Wagner, F. E. (2006). The stressor criterion in PTSD: notes on the genealogy of a problematic construct. American Journal of Psychotherapy, 60, 261–270.
Solomon, S. D., & Canino, G. J. (1990) Appropriateness of DSM-III-R criteria for posttraumatic stress disorder. Comprehensive Psychiatry, 312, 227–237.
Spitzer, C., AbrahamsonG., ReschkeK., et al. (2000). Posttraumatic stress disorder following high- and low-magnitude stressors in psychotherapeutic inpatients. Clinical Psychology and Psychotherapy, 7, 379–384.
Spitzer, R., Williams, J., & Gibbon, M. (1987). Structured Clinical Interview for DSM-III-R, Version NP-V. New York, NY: New York State Psychiatric Institute, Biometrics Research Department.
Suvak, M., Maguen, S., Litz, B. T., Silver, R. C., & Holman, E. A. (2008). Indirect exposure to the September 11 terrorist attacks: Does symptom structure resemble PTSD?Journal of Traumatic Stress, 21, 30–39.
Van Hoof, M., McFarlane, A. C., Baur, J., Abraham, M., & Barnes, D. J. (2009). The stressor criterion-A1 and PTSD: a matter of opinion?Journal of Anxiety Disorders, 232, 77–86.
Weathers, F. W., & Keane, T. M. (2007). The Criterion A problem revisited: controversies and challenges in defining and measuring psychological trauma. Journal of Traumatic Stress, 20, 107–121.
Weathers, F. W., Litz, B. T., Herman, D. S., & Keane, T. M. (1993). The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Paper presented at the annual meeting of the International Society for Traumatic Stress Studies, San Antonio, Texas.
Weiss, D. S., & MarmarC. R. (1997). The Impact of Event Scale-Revised. In J. P. Wilson & T. M. Keane, eds., Assessing Psychological Trauma and PTSD. New York, NY: Guilford Press.
Wessely, S. (2005). Risk, psychiatry and the military. British Journal of Psychiatry, 186, 459–566.
World Health Organization (1990). Composite International Diagnostic Interview (CIDI). Geneva: World Health Organization.
World Health Organization (1997). Composite International Diagnostic Interview (CIDI), Version 2.1. Geneva: World Health Organization.
Yehuda, R., & McFarlane, A. C. (1995). Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. American Journal of Psychiatry, 152, 1705–1713.

References

Ainsworth, M. (1969). Object relations, dependency and attachment: a theoretical review of the infant–mother relationship. Child Development, 40, 969–1025.
Ainsworth, M. (1991). An ethological approach to personality development. American Psychologist, 46, 333–341.
Ainsworth, M., Blehar, M. C., Waters, E., & Wall, S. (1978). Patterns of Attachment: a Psychological Study of the Strange Situation. Hillsdale, NJ: Lawrence Erlbaum.
Armsden, G. C., & Greenberg, M. T. (1987). The inventory of parent and peer attachment: Individual differences and their relationship to psychological well-being in adolescence. Journal of Youth and Adolescence, 16, 427–454.
Armstrong, S., & Roth, D. (1989). Attachment and separation difficulties in eating disorders: A preliminary investigation. International Journal of Eating Disorders, 8, 141–155.
Aschenbrand, S. G., Kendall, P. C., Webb, A., Safford, S. M., & Flannery-Schroeder, E. (2003). Is childhood separation anxiety disorder a predictor of adult panic disorder and agoraphobia? A seven-year longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1478–1485.
Bartholomew, K., & Horowitz, L. M. (1991). Attachment styles among young adults: a test of a four-category model. Journal of Personality and Social Psychology, 61, 226–244.
Beck, A. T. (1985). Cognitive Therapy and the Emotional Disorders. New York, NY: International Universities Press.
Bifulco, A., Kwon, J., Jacobs, C., et al. (2006). Adult attachment styles as mediator between childhood neglect/abuse and adult depression and anxiety. Social Psychiatry and Psychiatric Epidemiology, 41, 796–805.
Birmaher, B., Axelson, D. A., Monk, K., et al. (2003). Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 415–423.
Blanchard, E. B., Jones-Alexander, J., Buckley, T. C., & Forneris, C. A. (1996). Psychometric properties of the PTSD Checklist (PCL). Behavior Research and Therapy, 34, 669–673.
Bowlby, J. (1969). Attachment and Loss, Vol. 1: Attachment. New York, NY: Basic Books.
Bowlby, J. (1973). Attachment and Loss, Vol. 2: Separation: Anxiety and Anger. New York, NY: Basic Books.
Bowlby, J. (1977). The making and breaking of affectional bonds. British Journal of Psychiatry, 130, 201–210.
Bowlby, J. (1980). Attachment and Loss. Vol. 3: Loss, Sadness and Depression. New York, NY: Basic Books.
Bowlby, J. (1988). A Secure Base. New York, NY: Basic Books.
Briere, J., & Runtz, M. G. (1989). The Trauma Symptom Checklist (TSC-33): early data on a new scale. Journal of Interpersonal Violence, 4, 151–163.
Cantwell, D. P., & Baker, L. (1989). Stability and natural history of DSM-III childhood diagnoses. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 691–700.
Collins, N. L. (1996). Working models of attachment: Implications for explanation, emotion, and behavior. Journal of Personality and Social Psychology, 71, 810–832.
Collins, N. L., & Read, S. J. (1990). Adult attachment, working models, and relationship quality in dating couples. Journal of Personality and Social Psychology, 58, 644–663.
Cronk, N. J., Slutske, W. S., Madden, P. A., Bucholz, K. K., & Heath, A. C. (2004). Risk for separation anxiety disorder among girls: paternal absence, socioeconomic disadvantage, and genetic vulnerability. Journal of Abnormal Psychology, 113, 237–247.
Cyranowski, J. M., Shear, M. K., Rucci, P., et al. (2002). Adult separation anxiety: psychometric properties of a new structured clinical interview. Journal of Psychiatric Research, 36, 77–86.
Dallaire, D. H., & Weinraub, M. (2005). Predicting children’s separation anxiety at age 6: the contributions of infant–mother attachment security, maternal sensitivity, and maternal separation anxiety. Attachment and Human Development, 7, 393–408.
Declercq, F., & Palmans, V. (2006). Two subjective factors as moderators between critical incidents and the occurrence of post traumatic stress disorders: adult attachment and perception of social support. Psychology and Psychotherapy, 79, 323–337.
Dieperink, M., Leskela, J., Thuras, P., & Engdahl, B. (2001). Attachment style classification and posttraumatic stress disorder in former prisoners of war. American Journal of Orthopsychiatry, 71, 374–378.
Ellis, A. (1962). Reason and Emotion in Psychotherapy. Secaucus, NJ: Citadel Press.
FagioliniA., Shear, M. K., Cassano, G. B., & FrankE. (1998). Is lifetime separation anxiety a manifestation of panic spectrum?CNS Spectrums, 3, 63–72.
Foley, D. L., Pickles, A., Maes, H. M., Silberg, J. L., & Eaves, L. J. (2004). Course and short-term outcomes of separation anxiety disorder in a community sample of twins. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1107–1114.
Fonagy, P, & Target, M. (2005). Bridging the transmission gap: an end to an important mystery of attachment research?Attachment and Human Development, 7, 333–343.
George, C., Kaplan, N., & Main, M. (1985). The Berkeley Adult Attachment Interview. Berkeley, CA: University of California.
Hamilton, C. E. (2000). Continuity and discontinuity of attachment from infancy through adolescence. Child Development, 71, 690–694.
Hazan, C., & Shaver, P. (1987). Romantic love conceptualized as an attachment process. Journal of Personality and Social Psychology, 52, 511–524.
Hock, E., McBride, S, & Gnezda, M. (1989). Maternal separation anxiety: mother–infant separation from the maternal perspective. Child Development, 60, 79–802.
Hock, E., Eberly, M., Bartle-Haring, S., Ellwanger, P., & Widaman, K. F. (2001). Separation anxiety in parents of adolescents: theoretical significance and scale development. Child Development, 72, 284–298.
Hofer, M. (1984). Relationships as regulators: a psychobiologic perspective on bereavement. Psychosomatic Medicine, 46, 183–197.
Kendall, P. C. (1994). Treating anxiety disorders in children: results of a randomized clinical trial. Journal of Consulting and Clinical Psychology, 62, 100–110.
Klerman, G., Weissman, M., Rounseville, B., & Chevron, E. S. (1984). Interpersonal Psychotherapy for Depression. New York, NY: Basic Books.
Kobak, R. R., & Sceery, A. (1988). Attachment in late adolescence: working models, affect regulation, and representations of self and others. Child Development, 59, 135–146.
Last, C. G., Perrin, S., Hersen, M., & Kazdin, A. E. (1996). A prospective study of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1502–1510.
Maller, R G, & Reiss, S. (1992). Anxiety sensitivity in 1984 and panic attacks in 1987. Journal of Anxiety Disorders, 6, 241–247.
Manicavasagar, V., & Silove, D. (1997). Is there an adult form of separation anxiety disorder? A brief clinical report. Australian and New Zealand Journal of Psychiatry, 31, 299–303.
Manicavasagar, V., Silove, D., & Curtis, J. (1997). Separation anxiety in adulthood: a phenomenological investigation. Comprehensive Psychiatry, 38, 274–282.
Manicavasagar, V., Silove, D., Curtis, J., & Wagner, R. (2000). Continuities of separation anxiety from early life into adulthood. Journal of Anxiety Disorders, 14, 1–18.
Manicavasagar, V., Silove, D., Rapee, R., Waters, F., & Momartin, S. (2001). Parent–child concordance for separation anxiety: a clinical study. Journal of Affective Disorders, 65, 81–84.
Marcaurelle, R., Belanger, C., Marchand, A., Katerelos, T. E., & Mainguy, N. (2005). Marital predictors of symptom severity in panic disorder with agoraphobia. Journal of Anxiety Disorders, 19, 211–232.
Masi, G., Mucci, M., & Millepiedi, S. (2001). Separation anxiety disorder in children and adolescents: Epidemiology, diagnosis and management. CNS Drugs, 15, 93–104.
Mickelson, K. D., Kessler, R. C., & Shaver, P. (1997). Adult attachment in a nationally representative sample. Journal of Personality and Social Psychology, 73, 1092–1106.
Mikulincer, M., & Shaver, P. R. (2007). Attachment in Adulthood: Structure, Dynamics, and Change. New York, NY: Guilford Press.
Mikulincer, M., & Shaver, P. (2003). The attachment behavioral system in adulthood: activation, psychodynamics, and interpersonal processes. In M. P. Zanna, ed., Advances in Experimental Social Psychology, Vol. 35. New York, NY: Academic Press, pp. 53–152.
Mikulincer, M., Birnbaum, G., Woddis, D., & Nachmias, O. (2000). Stress and accessibility of proximity-related thoughts: exploring the normative and intraindividual components of attachment theory. Journal of Personality and Social Psychology, 78, 509–523.
Mikulincer, M., Shaver, P., & Pereg, D. (2003). Attachment theory and affect regulation: The dynamics, development, and cognitive consequences of attachment-related strategies. Motivation and Emotion, 27, 77–102.
Neria, Y., Guttman-Steinmetz, S., Koenen, K., et al. (2001). Do attachment and hardiness relate to each other and to mental health in real life stress?Journal of Social and Personal Relationships, 18, 844–858.
O’Connor, M., & Elklit, A. (2008). Attachment styles, traumatic events, and PTSD: a cross-sectional investigation of adult attachment and trauma. Attachment and Human Development, 10, 59–71.
Ollendick, T. H., Lease, C., & Cooper, C. (1993). Separation anxiety in young adults: a preliminary examination. Journal of Anxiety Disorders, 7, 293–305.
Panksepp, J. (2005). Why does separation distress hurt? Comment on MacDonald and Leary (2005). Psychological Bulletin, 131, 224–230; author reply 237–240.
Rector, N. A., Szacun-Shimizu, K., & Leybman, M. (2007). Anxiety sensitivity within the anxiety disorders: disorder-specific sensitivities and depression comorbidity. Behaviour Research and Therapy, 45, 197–1975.
Reiss, S. (1991). Expectancy model of fear, anxiety, and panic. Clinical Psychology Review, 11, 141–153.
Research Unit on Pediatric Psychopharmacology Anxiety Study Group (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344, 1279–1285.
Sable, P. (2008). What is adult attachment?Clinical Social Work Journal, 36, 21–30.
Scher, C. D., & Stein, M. B. (2003). Developmental antecedents of anxiety sensitivity. Anxiety Disorders, 17, 253–269.
Schmidt, N. B., Lerew, D. R., & Jackson, R. J. (1997). The role of anxiety sensitivity in the pathogenesis of panic: prospective evaluation of spontaneous panic attacks during acute stress. Journal of Abnormal Psychology, 106, 355–364.
Schmidt, N. B., Lerew, D. R., & Jackson, R. J. (1999). Prospective evaluation of anxiety sensitivity in the pathogenesis of panic: replication and extension. Journal of Abnormal Psychology, 108, 532–537.
Schore, A. N. (1996). The experience-dependent maturation of a regulatory system in the orbital prefrontal cortex and the origin of developmental psychopathology. Development and Psychopathology, 8, 59–87.
Schore, A. N. (2000). Attachment and the regulation of the right brain. Attachment and Human Development, 2, 23–47.
Schore, A. N. (2001). The effects of a secure attachment relationship on right brain development, affect regulation, and infant mental health. Infant Mental Health Journal, 22, 7–66.
Schore, A. N. (2002). Advances in neuropsychoanalysis, attachment theory, and trauma research: implications for self psychology. Psychoanalytic Inquiry, 22, 433–484.
Schore, J., & Schore, A. (2008). Modern attachment theory: the central role of affect regulation in development and treatment. Clinical Social Work Journal, 36, 9–20.
Shear, K., Jin, R., Ruscio, A. M., Walters, E. E., & Kessler, R. C. (2006). Prevalence and correlates of estimated DSM-IV child and adult separation anxiety disorder in the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 1074–1083.
Silove, D., Manicavasagar, V., Curtis, J., & Blaszczynski, A. (1996). Is early separation anxiety a risk factor for adult panic disorder? A critical review. Comprehensive Psychiatry, 37, 167–179.
Silverman, W. K., Kurtines, W. M., Ginsburg, G. S., et al. (1999). Treating anxiety disorders in children with group cognitive–behaviorial therapy: a randomized clinical trial. Journal of Consulting and Clinical Psychology, 67, 995–1003.
Solomon, Z., Ginzburg, K., Mikulincer, M., Neria, Y., & Ohry, A. (1998). Coping with war captivity: the role of attachment style. European Journal of Personality, 12, 271–285.
Stein, M. B., Jang, K. L., & Livesley, W. J. (1999). Heritability of anxiety sensitivity: a twin study. American Journal of Psychiatry, 156, 246–251.
Stewart, S. H., & Watt, M. C. (2008). Introduction to the special issue on interoceptive exposure in the treatment of anxiety and related disorders: novel applications and mechanisms of action. Journal of Cognitive Psychotherapy, 22, 291–302.
Taylor, S., Koch, W. J., & McNally, R. J. (1992). How does anxiety sensitivity vary across the anxiety disorders?Journal of Anxiety Disorders, 6, 249–259.
Viana, A. G., & Rabian, B. (2008). Perceived attachment: relations to anxiety sensitivity, worry, and GAD symptoms. Behaviour Research and Therapy, 46, 737–747.
Walkup, J. T., Albano, A. M., Piacentini, J., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359, 2753–2766.
Warren, S. L., Huston, L., Egeland, B., & Sroufe, L. A. (1997). Child and adolescent anxiety disorders and early attachment. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 637–644.
Waters, E., Weinfield, N. S., & Hamilton, C. E. (2000). The stability of attachment security from infancy to adolescence and early adulthood: general discussion. Child Development, 71, 703–706.
Watt, M. C., Stewart, S. H., & Cox, B. J. (1998). A retrospective study of the learning history origins of anxiety sensitivity. Behaviour Research and Therapy, 36, 505–525.
Watt, M. C., McWilliams, L. A., & Campbell, A. G. (2005). Relations between anxiety sensitivity and attachment style dimensions. Journal of Psychopathology and Behavioral Assessment, 27, 191–200.
Weems, C., & Carrion, V. (2003). The treatment of separation anxiety disorder employing attachment theory and cognitive behavior therapy techniques. Clinical Case Studies, 2, 188–198.
Weems, C., Berman, S., Silverman, W., & Saavedra, L. (2001). Cognitive errors in youth with anxiety disorders: the linkages between negative cognitive errors and anxious symptoms. Cognitive Therapy and Research, 25, 559–575.
Weems, C., Berman, S., Silverman, W., & Rodriquez, E. (2002). The relation between anxiety sensitivity and attachment style in adolescence and early adulthood. Journal of Psychopathology and Behavioral Assessment, 24, 159–168.
Wijeratne, C., & Manicavasagar, V. (2003). Separation anxiety in the elderly. Journal of Anxiety Disorders, 17, 695–702.

References

Amaral, D. G., & Price, J. L. (1984). Amygdalo-cortical projections in the monkey (Macaca fascicularis). Journal of Computational Neurology, 230, 465–496.
AyanlarBatuman, O., Ferrero, A. P., Diaz, A., & Jimenez, S. A. (1991). Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. Journal of Clinical Investigation, 88, 1574–1580.
Barros, M., & Tomaz, C. (2002). Non-human primate models for investigating fear and anxiety. Neuroscience and Biobehavioral Review, 26, 187–201.
Cirulli, F., Francia, N., Branchi, I., et al. (2009). Changes in plasma levels of BDNF and NGF reveal a gender-selective vulnerability to early adversity in rhesus macaques. Psychoneuroendocrinology, 34, 172–180.
Coplan, J. D., Rosenblum, L. A., Friedman, S., Bassoff, T. B., & Gorman, J. M. (1992). Behavioral effects of oral yohimbine in differentially reared nonhuman primates. Neuropsychopharmacology, 6, 31–37.
Coplan, J. D., Andrews, M. W., Rosenblum, L. A., et al. (1996). Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proceedings of the National Academy of Sciences of the USA, 93, 1619–1623.
Coplan, J. D., Trost, R. C., Owens, M. J., et al. (1998). Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions. Archives of General Psychiatry, 55, 473–477.
Coplan, J. D., Smith, E. L., Trost, R. C., et al. (2000). Growth hormone response to clonidine in adversely reared young adult primates: relationship to serial cerebrospinal fluid corticotropin-releasing factor concentrations. Psychiatry Research, 95, 93–102.
Coplan, J. D., Mathew, S. J., Smith, E. L., et al. (2001). Effects of LY354740, a novel glutamatergic metabotropic agonist, on nonhuman primate hypothalamic-pituitary-adrenal axis and noradrenergic function. CNS Spectrums, 6, 607–612, 617.
Davidson, R. J., Lewis, D. A., Alloy, L. B., et al. (2002). Neural and behavioral substrates of mood and mood regulation. Biological Psychiatry, 52, 478–502.
De Bellis, M. D., Keshavan, M. S., Spencer, S., & Hall, J. (2000). N-Acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD. American Journal of Psychiatry, 157, 1175–1177.
Drevets, W. C. (2000). Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Progress in Brain Research, 126, 413–431.
Etkin, A., & Wager, T. D. (2007). Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry, 164, 1476–1488.
Fergus, S., & Zimmerman, M. A. (2005). Adolescent resilience: a framework for understanding healthy development in the face of risk. Annual Review of Public Health, 26, 399–419.
Glaser, D. (2000). Child abuse and neglect and the brain: a review. Journal of Child Psychology and Psychiatry, 41, 97–116.
Goldberg, S., Muir, R., & Kerr, J. (1995). Attachment Theory: Social, Developmental, and Clinical Perspectives. Hillsdale, NJ: Analytic Press.
Gorman, J. M., Kent, J. M., Sullivan, G. M., & Coplan, J. D. (2000). Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry, 157, 493–505.
Gould, E., Tanapat, P., McEwen, B. S., Flugge, G., & Fuchs, E. (1998). Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proceedings of the National Academy of Sciences of the USA, 95, 3168–3171.
Greenberg, B. D., Askland, K. D., & Carpenter, L. L. (2008). The evolution of deep brain stimulation for neuropsychiatric disorders. Frontiers in Bioscience, 13, 4638–4648.
Gunnar, M. R., Brodersen, L., Nachmias, M., Buss, K., & Rigatuso, J. (1996). Stress reactivity and attachment security. Developmental Psychobiology, 29, 191–204.
Hajek, T., Kopecek, M., Kozeny, J., et al. (2009). Amygdala volumes in mood disorders: meta-analysis of magnetic resonance volumetry studies. Journal of Affective Disorders, 115, 395–410.
Harlow, H. F., & Suomi, S. J. (1974). Induced depression in monkeys. Behavioral Biology, 12, 273–296.
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological Psychiatry, 54, 1389–1398.
Herman, J. P., Figueiredo, H., Mueller, N. K., et al. (2003). Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo–pituitary–adrenocortical responsiveness. Frontiers in Neuroendocrinology, 24, 151–180.
Holmes, A., Murphy, D. L., & Crawley, J. N. (2003). Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biological Psychiatry, 54, 953–959.
Izquierdo, A., Suda, R. K., & Murray, E. A. (2004). Bilateral orbital prefrontal cortex lesions in rhesus monkeys disrupt choices guided by both reward value and reward contingency. Journal of Neuroscience, 24, 7540–7548.
Kalin, N. H. (2004). Studying non-human primates: a gateway to understanding anxiety disorders. Psychopharmacological Bulletin, 38 (Suppl. 1), 8–13.
Kalin, N. H., & Shelton, S. E. (2003). Nonhuman primate models to study anxiety, emotion regulation, and psychopathology. Annals of the New York Academy of Sciences, 1008, 189–200.
Kalin, N. H., Shelton, S. E., & Takahashi, L. K. (1991). Defensive behaviors in infant rhesus monkeys: ontogeny and context-dependent selective expression. Child Development, 62, 1175–1183.
Kalin, N. H., Shelton, S. E., & Davidson, R. J. (2004). The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate. Journal of Neuroscience, 24, 5506–5515.
Kalin, N. H., Shelton, S. E., & Davidson, R. J. (2007). Role of the primate orbitofrontal cortex in mediating anxious temperament. Biological Psychiatry, 62, 1134–1139.
Kaufman, J., Plotsky, P. M., Nemeroff, C. B., & Charney, D. S. (2000). Effects of early adverse experiences on brain structure and function: clinical implications. Biological Psychiatry, 48, 778–790.
Kaufman, D., Banerji, M. A., Shorman, I., et al. (2007). Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques. Diabetes, 56, 1382–1386.
Krabbe, K. S., Nielsen, A. R., Krogh-Madsen, R., et al. (2007). Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia, 50, 431–438.
Lyons, D. M., Yang, C., Sawyer-Glover, A. M., Moseley, M. E., & Schatzberg, A. F. (2001). Early life stress and inherited variation in monkey hippocampal volumes. Archives of General Psychiatry, 58, 1145–1151.
Lyons, D. M., Afarian, H., Schatzberg, A. F., Sawyer-Glover, A., & Moseley, M. E. (2002). Experience-dependent asymmetric variation in primate prefrontal morphology. Behavioral Brain Research, 136, 51–59.
Maestripieri, D., McCormack, K., Lindell, S. G., Higley, J. D., & Sanchez, M. M. (2006). Influence of parenting style on the offspring’s behaviour and CSF monoamine metabolite levels in crossfostered and noncrossfostered female rhesus macaques. Behavioral Brain Research, 175, 90–95.
Mathew, S. J., Coplan, J. D., Schoepp, D. D., et al. (2001). Glutamate-hypothalamic-pituitary-adrenal axis interactions: implications for mood and anxiety disorders. CNS Spectrums, 6, 555–556, 561–554.
Mathew, S. J., Shungu, D. C., Mao, X., et al. (2003). A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressors. Biological Psychiatry, 54, 727–735.
Meaney, M. J., & Szyf, M. (2005). Maternal care as a model for experience-dependent chromatin plasticity?Trends in Neuroscience, 28, 456–463.
Mirescu, C., & Gould, E. (2006). Stress and adult neurogenesis. Hippocampus, 16, 233–238.
Nelson, E. E., & Winslow, J. T. (2009). Non-human primates: model animals for developmental psychopathology. Neuropsychopharmacology, 34, 90–105.
Nemeroff, C. B., & Vale, W. W. (2005). The neurobiology of depression: inroads to treatment and new drug discovery. Journal of Clinical Psychiatry, 66 (Suppl. 7), 5–13.
Ochsner, K. N., & Gross, J. J. (2005). The cognitive control of emotion. Trends in Cognitive Science, 9, 242–249.
Onen Sertoz, O., Tolga Binbay, I., Koylu, E., et al. (2008). The role of BDNF and HPA axis in the neurobiology of burnout syndrome. Progress in Neuropsychopharmacology and Biological Psychiatry, 32, 1459–1465.
Parker, K. J., Buckmaster, C. L., Schatzberg, A. F., & Lyons, D. M. (2004). Prospective investigation of stress inoculation in young monkeys. Archives of General Psychiatry, 61, 933–941.
Parker, K. J., Buckmaster, C. L., Justus, K. R., Schatzberg, A. F., & Lyons, D. M. (2005a). Mild early life stress enhances prefrontal-dependent response inhibition in monkeys. Biological Psychiatry, 57, 848–855.
Parker, K. J., Buckmaster, C. L., Schatzberg, A. F., & Lyons, D. M. (2005b). Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology, 30, 924–929.
Parker, K. J., Buckmaster, C. L., Sundlass, K., Schatzberg, A. F., & Lyons, D. M. (2006). Maternal mediation, stress inoculation, and the development of neuroendocrine stress resistance in primates. Proceedings of the National Academy of Sciences of the USA, 103, 3000–3005.
Parker, K. J., Rainwater, K. L., Buckmaster, C. L., et al. (2007). Early life stress and novelty seeking behavior in adolescent monkeys. Psychoneuroendocrinology, 32, 785–792.
Perlis, R. H., Mischoulon, D., Smoller, J. W., et al. (2003). Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biological Psychiatry, 54, 879–883.
Perna, G., Favaron, E., Di Bella, D., Bussi, R., & Bellodi, L. (2005). Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology, 30, 2230–2235.
Price, J. L., & Amaral, D. G. (1981). An autoradiographic study of the projections of the central nucleus of the monkey amygdala. Journal of Neuroscience, 1, 1242–1259.
Prost, R. W., Mark, L., Mewissen, M., & Li, S. J. (1997). Detection of glutamate/glutamine resonances by 1H magnetic resonance spectroscopy at 0.5 tesla. Magnetic Resonance in Medicine, 37, 615–618.
Rolls, E. T. (2004). The functions of the orbitofrontal cortex. Brain and Cognition, 55, 11–29.
Rosenblum, L. A., & Paully, G. S. (1984). The effects of varying environmental demands on maternal and infant behavior. Child Development, 55, 305–314.
Rosenblum, L. A., & Paully, G. S. (1987). Primate models of separation-induced depression. Psychiatric Clinics of North America, 10, 437–447.
Rosenblum, L. A., Coplan, J. D., Friedman, S., et al. (1994). Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates. Biological Psychiatry, 35, 221–227.
Rosenblum, L. A., Forger, C., Noland, S., Trost, R. C., & Coplan, J. D. (2001). Response of adolescent bonnet macaques to an acute fear stimulus as a function of early rearing conditions. Developmental Psychobiology, 39, 40–45.
Sanchez, M. M. (2006). The impact of early adverse care on HPA axis development: nonhuman primate models. Hormones and Behavior, 50(4), 623–631.
Sanchez, M. M., Ladd, C. O., & Plotsky, P. M. (2001). Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Developmental Psychopathology, 13, 419–449.
Sanchez, M. M., Noble, P. M., Lyon, C. K., et al. (2005). Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biological Psychiatry, 57, 373–381.
Schuff, N., Neylan, T. C., Lenoci, M. A., et al. (2001). Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biological Psychiatry, 50, 952–959.
Serretti, A., Calati, R., Mandelli, L., & De Ronchi, D. (2006). Serotonin transporter gene variants and behavior: a comprehensive review. Current Drug Targets, 7, 1659–1669.
Smith, E. L., Batuman, O. A., Coplan, J. D., & Rosenblum, L. A. (2001). Stress, peer affiliation, and transforming growth factor-β1 in differentially reared primates. CNS Spectrums, 6, 573–578.
Smith, E. L., Batuman, O. A., Trost, R. C., Coplan, J. D., & Rosenblum, L. A. (2002). Transforming growth factor-beta 1 and cortisol in differentially reared primates. Brain Behavioral Immunology, 16, 140–149.
Sternberg, E. M. (1997). Neural–immune interactions in health and disease. Journal of Clinical Investigation, 100, 2641–2647.
Suomi, S. J. (1997). Early determinants of behaviour: evidence from primate studies. British Medical Bulletin, 53, 170–184.
Suomi, S. J. (2006). Risk, resilience, and gene × environment interactions in rhesus monkeys. Annals of the New York Academy of Sciences, 1094, 52–62.
Taylor, S. E., Eisenberger, N. I., Saxbe, D., Lehman, B. J., & Lieberman, M. D. (2006). Neural responses to emotional stimuli are associated with childhood family stress. Biological Psychiatry, 60, 296–301.